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Coronary artery disease (or heart disease) is a group of diseases that can cause heart 
attacks. Coronary artery disease is the leading cause of death for adults globally and it can be 
blamed for even more deaths in developed countries (Peterson, Syndergaard, Bowler, & Doxey, 
2012) and it carries the risk of acute coronary syndrome.  Acute coronary syndrome (ACS) is an 
umbrella term that can include any of the three following more specific syndromes; unstable 
angina, non-ST segment myocardial infarction or a heart attack (NSTEMI), and ST-segment 
elevation or heart attack (STEMI).  All three of these terms are associated with a sudden rupture 
of plaque inside the coronary artery.  The location of the blockage, the amount of time in which 
the blood flow to the myocardium (i.e., heart muscle) is occluded, and the amount of damage 
determines which type of acute coronary syndrome is occurring (Cleveland Clinic, 2015). 
Door to balloon time (D2B) is the time from the arrival of an STEMI patient at a hospital 
to the time of percutaneous coronary intervention (PCI).  The ACC/AHA, the Joint Commission 
Core Measures, and the European Society of Cardiology state the D2B time recommended to be 
within a 90 minute time frame (Antman et al, 2008; Silber et al., 2005) and within a 120 minute 
timeframe for transfer patients (ACC/AHA guidelines in 2002).  There are multiple other studies 
that support the relationship between decreased morbidity/mortality and D2B time.  Those 
studies also suggest a continuous relationship between shorter D2B times and better survival for 
patients who undergo primary PCI for a STEMI (Antonuicci et al, 2002; Berger et al, 1999; 
Cannon et al, 2000; McNamara et al, 2006; Brodie et al, 2001). 
The ACC/AHA guidelines state that PCI is preferred over fibrinolytics as the method of 
reperfusion for patients who present with a STEMI.  However, only forty percent are treated 
within the AHA’s recommended door-to-balloon timeframe of 90 minutes (Jacobs, Antman, 
Faxon, Gregory, & Solis, 2007).  This is only true when PCI can be performed in a time sensitive 
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manner after the onset of symptoms and by experienced operators (Antman et al., 2004). 
However, universal access is a problem and is a significant limitation in treating a STEMI patient 
with PCI, because PCI is only available in 25 percent of U.S. hospitals (Nallamothu, Bates, 
Wang, Bradley, & Krumholz, 2006). 
The focus of this practice inquiry project was to determine if implementation of a STEMI 
network could decrease the D2B times for walk-in, EMS, and transfer patients who present with 
a STEMI.  The first manuscript is a review of studies published between 1995 and 2014 that 
described the effects of implementing a STEMI network into different geographical regions of 
care and to investigate the use of STEMI Networks in the United States and throughout other 
countries.  During the review, a variety of evidence based techniques to implement hospital 
processes and regionalized systems to help in decreasing D2B times in patients who presented 
with STEMIs were identified.  However, there were no articles specific to STEMI Networks in 
the Kentucky area.  The performance of primary PCI in a time sensitive manner is the preferred 
method of treatment for a STEMI, and according to the BRFSS (2012) approximately 6.6 percent 
of adults in Kentucky have been told by a health care professional that they have had a heart 
attack, compared to the national percentage of 4.5 percent.  Therefore the purpose of the second 
manuscript was to evaluate whether or not the implementation of a STEMI Network in a 462-bed 
metropolitan hospital in Kentucky would help to decrease the D2B times of those patients who 
presented with a STEMI as walk-ins, EMS, or transfers.  The third and final manuscript includes 
a review of studies that highlight the disparity between socioeconomic status (SES) and 
cardiovascular disease (CVD).  Given that Kentucky has 19.1 percent of its population living in 
poverty, compared to 15.9 percent overall in the U.S. (KDPH, 2013), the third manuscript 
suggests focus areas to attempt to decrease the disparities between SES and CVD.  
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Abstract 
Background: STEMIs are a type of coronary occlusion that deprives the heart of oxygen and 
nutrients thereby causing coronary ischemia, injury and possible irreversible damage to the 
myocardial tissue.  Several studies suggest that primary percutaneous intervention (PCI) is the 
preferred method of restoring blood flow to the blocked artery; however this is only true when it 
can occur in an expeditious manner. 
Objective:  To identify strategies other hospitals and systems of care have implemented to help 
decrease door to balloon (D2B) times for STEMI patients.  The goal is to determine if a STEMI 
network and regionalized system of care should be implemented in central Kentucky. 
Methods: This integrative literature review explores fifteen articles found in CINAHL, 
MEDLINE, and PUBMED.  These articles report on the utilization of various strategies in order 
to decrease D2B time in ST-elevation myocardial infarction (STEMI) patients.  
Findings: Although the articles vary in approach to reducing D2B times (e.g., EMS field 
activation, EMS direct transport to a primary PCI facility, hospital specific process changes, 
regionalization of systems coordinated care, and prompt data feedback), the overarching theme is 
that all of the approaches have independently helped in the reduction of D2B times and have 
provided STEMI patients with the timely care necessary to improve outcomes and adhere to the 
AHA recommended <90 minute treatment window. 
 Keywords:  STEMI Network, door to balloon time, STEMI D2B, acute myocardial 
infarction, walk-in D2B time, STEMI and ER/ED, and STEMI EMS
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Background 
According to the American Heart Association (AHA, 2013), every year in the United 
States there are more than 250,000 individuals who experience an ST-elevation myocardial 
infarction (STEMI), an out of the hospital cardiac arrest, or both.  A STEMI is a type of acute 
coronary syndrome (ACS) and can be accompanied by life threatening complications.  ACS is a 
process caused by a coronary occlusion that may precipitate ischemia or infarction.  This 
occlusion deprives the heart muscle of oxygen and nutrients, causing possible irreversible 
damage if the myocardial tissue is not reperfused rapidly (Alspach, 2006).  There are several 
acute and life threatening complications that can occur from a STEMI, including cardiogenic 
shock, heart failure, ventricular tachycardia, atrial fibrillation, symptomatic bradycardia, acute 
mitral regurgitation, and sudden cardiac death (Learn the Heart, 2013).   
The American College of Cardiology (ACC), the AHA, and the Joint Commission Core 
Measures published the current recommended door to balloon (D2B) time as within a 90 minute 
time frame (Antman, Hand, & Armstrong, 2007).  For every 15 minute time period beyond 90 
minutes there is an associated increased risk of in-hospital death from complications.  Despite 
this widespread knowledge, the vast majority of these individuals fail to receive the appropriate 
treatment for this life-threatening condition within the recommended timeframe (Nallamothu, 
Bradley, & Krumholz, 2007a). 
Mission Lifeline (ML) is a national initiative set forth by the AHA (AHA-ML) to help 
advance the systems of care for patients presenting with a STEMI. Jacobs, Antman, Faxon, 
Gregory, and Solis (2007), state that thirty percent of STEMI patients fail to receive 
percutaneous coronary intervention (PCI) or fibrinolytic therapy (lytics) during their hospital 
stay.  According to the authors, of those patients who do receive immediate PCI, only forty 
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percent are treated within the AHA’s recommended door-to-balloon timeframe of 90 minutes.  
Additionally, fewer than half the patients who are treated with fibrinolytic therapy are treated 
within the AHA recommended door-to-needle timeframe of 30 minutes.  Furthermore, of the 
population of patients who are not eligible for thrombolytic therapy, seventy percent of those 
patients fail to receive PCI, which is the only other option to restore blood flow to blocked 
coronary arteries (Jacobs et al., 2007).  AHA-ML is working to improve these statistics and the 
overall quality of care while reducing the mortality and morbidity (e.g., cardiogenic shock, fatal 
dysrhythmias, mechanical incompetencies, etc.) for STEMI patients.  The statistics presented by 
the AHA are evidence that the majority of healthcare systems have a great deal of improvements 
to make when it comes to caring for STEMI patients according to the guidelines set forth by the 
AHA.  
In 2004, Antman et al. conducted trials which demonstrated that the transfer of patients 
for PCI will still produce superior outcomes when compared with fibrinolysis (lytics) at a non-
PCI capable hospital.  From these studies, consistent with the ACC/AHA guidelines, it was 
determined that PCI is preferred over lytics as the method of reperfusion for patients who present 
with a STEMI.  However, this is only true when PCI can be performed in a time sensitive 
manner after the onset of symptoms and by experienced operators (Antman et al., 2004).  
However, universal access is a problem and is a significant limitation in treating a STEMI patient 
with PCI, because PCI is only available in 25 percent of U.S. hospitals (Nallamothu, Bates, 
Wang, Bradley, & Krumholz, 2006).  In addition to the lack of availability of PCI-capable 
hospitals, there is also a lack of organized care systems as well as a lack of an integrated system 
of care for transfer patients identified as having a STEMI (Jacobs et al., 2006).  This is evidenced 
by reports that the median D2B time for patients who are transferred for PCI is 180 minutes 
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(Henry et al., 2007; Nallamothu et al., 2005).  Moreover, only 4.2 percent of transferred patients 
are treated within 90 minutes, which is the guideline set by the ACC/AHA (AHA, 2013).  
According to Jacobs et al. (2007), there are practically 5,000 acute care hospitals in the 
U.S. However, only 44 percent of those have a cardiac catheterization lab and only 24 percent 
have the capabilities of performing PCI.  It is because only 24 percent of hospitals have the 
ability to perform PCI that creating a coordinated system of care is crucial to helping deliver PCI 
in the timeliest manner to those patients who present with a STEMI.  Similar to Jacobs et al. 
(2006), this practice inquiry will define a STEMI Network as “an integrated group of separate 
entities within a region providing specific services for the system that could include emergency 
medical services (EMS) providers, a community hospital(s), a tertiary center(s), and others” (p. 
217).  
Purpose of Review 
The purpose of this integrative review is to identify and critique research designed to 
investigate the use of STEMI Networks in the United States and throughout other countries.  
Additionally, this review will examine the use and efficacy of STEMI Networks and regionalized 
systems of care to decrease the STEMI door to balloon (or device) treatment time of patients 
who present to a hospital via walk-in, transfer, or EMS.  This review will also identify gaps in 
the literature and provide recommendations for future research and practice. 
Method 
A predefined strategy was used to extract the most current and relevant research from the 
available literature for this integrative review.  A comprehensive search of the Cumulative Index 
of Nursing and Allied Health Literature (CINAHL), Medical Literature Analysis and Retrieval 
System Online (MEDLINE), and PUBMED databases was conducted. Searches of the reference 
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lists of retrieved papers were also performed for references within relevant journals.  The 
selection criteria for these searches included systematic review articles, meta-analyses, and 
clinical trials/studies in English.  The keywords to search the literature included the following: 
STEMI Network, door to balloon time, STEMI D2B, acute myocardial infarction, walk-in D2B 
time, STEMI and emergency room/emergency department (ER/ED), and STEMI emergency 
medical services (EMS).  The terms were searched independently and then combined.   
The goal of this review was to identify published clinical research to determine the impact 
of organized STEMI Networks and regional systems of care for patients who present with a 
STEMI.  Inclusion criteria were as follows: full text, peer reviewed nursing or medical journal 
articles published in English between the years 1995 and 2014.  Additionally, the selected studies 
were included if they met the following criteria: 1) studies conducted with adults aged 18 years 
and older, 2) studies that focused on system improvements (i.e., PCI receiving hospital, PCI 
referring hospital, EMS), and 3) articles extracted from the database search were then 
systematically reviewed for clinical significance (i.e., sample characteristics, the setting, data 
collection, inclusion criteria of specific populations, findings and conclusion) and relevance.  
References of the selected articles were also reviewed and evaluated for potential application to 
the clinical topic.  Studies that were qualitative in nature were excluded from this literature 
review.  This search revealed 47 articles, and after evaluation of inclusion/exclusion factors, 15 
were reviewed.  The articles that were identified included topics such as process improvements, 
regional network implementation, streamlining referral protocols, use of a “code STEMI” or 
“code AMI”.  These 15 articles are discussed in further detail below and identified in Table 1. 
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Summary of Findings 
EMS and D2B Times 
The impact of EMS on D2B times was recognized as main focal points in six of the 
fifteen articles (Cone, Lee, & Van Gelder, 2013; Cheskes et al., 2011; Camp-Rogers et al., 2011; 
Fosbol et al., 2013; Eckstein, Koenig, Kaji, & Tadeo, 2009; Caudle, Piggott, Dostaler, Graham, 
& Brison, 2009).  These six articles all recognized EMS as belonging to part of a 
multidisciplinary team and the need for EMS companies to develop protocols for a prehospital 
assessment, triage, and treatment of patients who have a suspected STEMI.  These six articles 
were further separated into the two themes of field activation and direct transport.  Field 
activation can be defined as EMS activation of a nearby PCI capable ER/ED whereas direct 
transport can be defined as EMS patients who were sent directly to a PCI capable facility, 
bypassing other hospitals in the process.  
Field Activation. Field activation data were collected in three of the six EMS specific 
articles.  These studies are listed in Table 2 for further review.  These three studies examined 
D2B times and EMS compliance with a national 90 minute performance benchmark (Cone, Lee, 
& Van Gelder, 2013; Cheskes et al., 2011; Camp-Rogers et al., 2011).  The studies revealed that 
EMS field activation can significantly improve the proportion of patients with a first medical 
contact (FMC) to balloon time of less than 90 minutes. In addition to these findings, one of these 
studies also sought to evaluate the accuracy of EMS activation of the cardiac cath lab for patients 
with a STEMI (Camp-Rogers et al., 2011).  The authors conducted a pre/post cohort study of 
patients presenting via EMS with pre-hospital EKG that showed a STEMI. Before the date of 
August 20, 2007 preparation for the patient to go to the cath lab for treatment with PCI was 
initiated after the patient arrived at the hospital. After the August 20, 2007 date, a protocol was 
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developed that enabled EMS providers to activate the cath lab if the prehospital EKG indicated 
STEMI.  All times were measured by clocks that were synchronized between the time that EMS 
was dispatched until PCI. A total of 53 patients, 14 pre and 39 post-hospital activation were 
included.  The results showed that prehospital activation of the cath lab significantly improved 
mean D2B time by 18.2 minutes (95% CI, 7.69-28.71 minutes; p = .0029) and door-to-cath lab 
by 14.8 minutes (95% CI, 6.20-23.39 minutes; p = .0024).  There were significant time savings 
reflected in all EMS intervals (e.g., mean dispatch-to-reperfusion time, in mean FMC-to-
reperfusion time, and in recognition-to-reperfusion time).  This supported the assumption that 
EMS providers can appropriately activate the cardiac cath lab team for patients with a STEMI 
before the patient’s ER arrival thereby helping to decrease D2B time.  
Direct Transport.  The remaining three studies from the six that examined the role of 
EMS in D2B times for STEMI patients assessed adherence to a variety of protocols that were 
developed to facilitate direct transport to a PCI capable facility (Fosbol et al., 2013; Eckstein, 
Koenig, Kaji, & Tadeo, 2009; Caudle, Piggott, Dostaler, Graham, & Brison, 2009).  Results from 
these three studies independently determined that patients who were sent directly to a PCI center 
had significantly shorter times to reperfusion and a greater likelihood of meeting the STEMI 
treatment guidelines.  These patients were more likely to have a D2B time of less than 90 
minutes. In a study by Eckstein et al. (2009), the authors found after the implementation of a 
regional STEMI system that D2B times within the 90 minute benchmark were achieved for 
nearly ninety percent of STEMI patients who were transported by EMS providers. Interestingly, 
Eckstein et al. (2009) reported that nationally, only four percent of STEMI patients who are 
taken for primary PCI have a D2B time of less than 90 minutes. 
12 
 
Fosbol et al. (2013) assessed the adherence of EMS to STEMI protocol that advised 
paramedics to bypass local hospitals and transport STEMI patients directly to PCI-capable 
hospitals, even if a non-PCI-hospital is closer. In this large 6,010 patient study, the patients were 
divided into those who were directly transported to a PCI-capable hospital (who thereby passed a 
smaller non-PCI-capable hospital), and those who were first taken to a non-PCI-capable hospital 
and then later transferred to a PCI hospital.  Of the 6,010 patients, 1,288 were eligible and 
included in the study cohort.  The authors found that those patients who were went directly to a 
PCI-capable hospital were more likely to have times that were within the recommended D2B 
times.  Specifically, the authors found that patients who were sent to PCI-capable hospitals had a 
significantly shorter time to reperfusion.  
Process Flow and D2B Times 
The remaining nine articles fell into a general category of examining the process flow of a 
STEMI patient once medical contact has been established.  This category can include EMS, 
transfer patients, and walk-in patients and their flow through the medical system.  The process 
flow themes can be further broken down (seen in Table 3) into process changes within the 
hospital and include the implementation of: 1) a “code STEMI” or “code AMI” (Bajaj et al., 
2012; Ahmar, Quarin, Ajani, Kennedy, & Grigg, 2008), 2) hospital specific process changes 
(Ahmar, Quarin, Ajani, Kennedy, & Grigg, 2008; Clark et al., 2012; Pan et al., 2014; Niles et al., 
2010), 3) a regionalization of facilities that cooperate together for the improvement of D2B times 
(Kalla et al., 2006; Saia et al., 2009; Reimer, Hustey, & Kralovic, 2013), and  4) self-reporting 
and process reviews (Kelly et al., 2010; Niles et al., 2010). 
Code STEMI and Code AMI.  Two of the nine articles in the category of process flow 
compared D2B times pre and post implementation of the initiation of a “code AMI” or “code 
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STEMI” for off-hour STEMIs (Bajaj et al., 2012; Ahmar, et al., 2008).  The activation of a “code 
STEMI” or a “code AMI”, for the purposes of this review, involved a single call from the 
emergency physician to a central phone number would simultaneously activate the on call 
interventionalist, the cardiac cath lab team, and the on call in house cardiology fellow, as well as 
the necessary administrators to plan for transfer, transport from the ED to the cath lab, and a 
hospital bed post PCI (Bajaj et al., 2012; Ahmar, et al., 2008).  Both studies reported that the 
implementation of the “code” at each of the institutions significantly reduced D2B times for off-
hour STEMIs.  Specifically, Bajaj et al. (2012) found that with the implementation of “code 
STEMI” protocol the median D2B time during off hours dropped to 77 minutes, which 
represents a 52 minute improvement.  EKG to cath lab time demonstrated a reduction of 16 
minutes.  Similarly, Ahmar et al. (2008) found that through changes that were implemented to 
improve off-hours D2B times (including the initiation of a “code AMI”), a 29 percent 
improvement was made in the off-hours D2B times and 69 percent of those cases were managed 
in under 90 minutes. 
Hospital-Specific Process Changes and D2B Time.  Four of the nine articles in this 
review examined multi-dimensional hospital-specific process changes.  These articles had a 
variety of process improvement techniques that were implemented.  For example, one of the 
studies utilized implementation of a computerized provider order entry (Pan et al., 2014).  
Another study (Niles et al., 2010) examined a hospital’s D2B process because only 33 percent of 
its STEMI patients had D2B times that were under 90 minutes.  The authors implemented the 
ST-elevation myocardial infarction process upgrade (STEPUP) project. In this project a 
multidisciplinary group was formed with members from cardiology, emergency medicine, EMS, 
hospital communications, coronary care, cardiac cath lab, and administration.  The mission of the 
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group was to identify and implement strategies to improve the process of care, treatment times, 
and outcomes of STEMI patients.  Examples of process improvements that were made included: 
1) ER physician activation of the cardiac cath lab, 2) a single phone call activation the cardiac 
cath lab by triggering STEMI alert pages to all necessary cardiac cath lab staff, 3) cardiac cath 
lab being ready to accept patients no greater than 30 minutes after the initial activation call, and 
4) a system of prompt data feedback with data recipients including EMS, ER, and cardiac cath 
lab personnel, etc.  
Similarly, Clark et al. (2012) and Ahmar et al. (2008) examined a variety of hospital 
processes such as the relationship of EMS intervals and internal hospital interval processes (i.e., 
EMS activation, door to page, page to cath lab, and lab to reperfusion) to the rapid reperfusion of 
patients with STEMIs.  Specifically, Ahmar et al (2008) explored the hospital practice of 
managing STEMIs by identifying processes that were associated with possible time delays in 
treating STEMI patients.  The authors subsequently looked for ways in which to improve the 
acute STEMI management system for both “on hours” and “off hours” patients.  The study group 
was made up of consecutive patients who presented to the hospital with a STEMI between April 
and September 2005 and the same period in 2006 and compared patients who presented “in 
hours” (0700 hours to 1800 hours (Monday to Friday)) versus out of hours (which was all other 
times including public holidays).  The authors found that the guideline recommendations for 
D2B times (90 min) were achieved during the “in hours” however during the “off hours”, times 
exceeded the recommended time frames. 
 The authors were able to identify several possible delays in achieving the recommended 
time frame of 90 minutes during all hours.  These potential delays included the performance and 
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analysis of EKGs, a decision made by the cardiology team, and transfer of the patient to the cath 
lab. Moreover, these delays were more significant in the “off hours” patients. 
Subsequently, there were several changes that were implemented in order to improve 
D2B time for both “on” and “off” hours.  For example, some changes that were made included 
(but were not limited to) changing hospital policy. That is, the hospital changed its policy so that 
all STEMI patients were first and foremost treated with primary PCI, which eliminated the need 
for the cardiologist to determine whether the treatment of choice would be lytics or PCI.  Second, 
there was focus placed on the ER performing immediate EKG after patient arrival to the hospital.  
Third, the ER was provided with direct telephone access to the cardiologist in order to provide 
more efficient cath lab activation.  
Implications all of these studies suggest that it is critical to use coordinated approach in 
conjunction with an ongoing review.  The previously mentioned studies strongly suggest that a 
multidisciplinary approach and a continuous feedback process through a quality improvement 
program are critical variables to consider when attempting to reduce the D2B times in STEMI 
patients.  
STEMI Networks and Regionalization and D2B Times.  Three of the nine articles 
specifically discussed and evaluated a streamlined interfacility referral protocol or a 
regionalization and network for treatment of STEMIs (Kalla et al., 2006; Saia et al., 2009; 
Reimer, Hustey, & Kralovic, 2013).  Many of the studies examined referral hospitals (e.g. non-
PCI capable hospitals that transfer patients out to PCI capable hospitals, which are also referred 
to as receiving centers).  These systems (or networks) focused on referral and transport 
processes. In one study, the traditional referral protocol was reviewed in order to identify areas 
for improvement by the transport team as well as cardiology management teams (Niles et al., 
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2010).  The authors identified one of the main points as being the benefit in providing a direct 
contact telephone number to a coordinator who could activate the cardiac cath lab team. 
Subsequently, that coordinator would obtain the information about the current STEMI patient 
(e.g., EKG, patient location, demographics, mode of transportation).  This would occur 
simultaneously while the coordinator activates the cardiac cath lab team and makes sure a table 
and bed are reserved and available by hospital administration.  The authors found that there were 
significant reductions in time to the first EKG in the ER and in D2B times.  This supports the 
necessity for continuous improvement in the process of STEMI patient care and constant 
education and re-education of the staff involved. 
Data Feedback and D2B Times.  Two studies of the nine used a self-reporting and 
immediate data feedback to assist in improving D2B times with patients who present with a 
STEMI (Kelly et al., 2010; Niles et al., 2010).  One study that occurred at Wake Forest Hospital 
used the Six Sigma methodology to aid in the improvement of hospital D2B times (Kelly et al., 
2010).  Six Sigma methodology is a quality improvement tool that was first developed and used 
by the Motorola Corporation in the 1970s (Harry, 2000).  This is an evaluation tool that has more 
recently been adapted to use in the medical field in order to attempt to be more efficient and 
create less error.  Specifically, Six Sigma can be useful to analyze and modify complicated and 
time sensitive processes that involve multiple disciplines and treatment areas (e.g., EMS, ED, 
cath lab).  Consequently, this tool is particularly useful in exploring any issues with the rapid 
reperfusion of patients who present with a STEMI.  Thus, the authors reported that after process 
analysis and implementation of improvements, mean D2B times decreased from 128 minutes to 
90 minutes.  This improvement was sustained. Additionally, as of June 2010, the year of 
publication, the mean D2B was 56 minutes with 100% of the patients who present with STEMI 
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meeting the 90 minute window.  Both studies, Niles et al. (2010) and Kelly et al. (2010), 
demonstrate the effectiveness of prompt provider data feedback and its positive impact on 
helping to decrease D2B times of STEMI patients. 
Gaps and Barriers 
The articles in this review used a variety of evidence based techniques to implement 
hospital processes and regionalized systems to help in decreasing D2B times in patients who 
presented with STEMIs; however, there were no articles specific to STEMI Networks in the 
Kentucky area.  This is an important consideration and a major gap in the literature because 
according to the BRFSS (2012), approximately 6.6 percent of adults in Kentucky have been told 
by a health care professional that they have had a heart attack, compared to the national 
percentage of 4.5 percent.  Further research and data analysis needs to be performed on the 
effects of a STEMI Network in this specific region in the southeastern United States. 
The benefit of timely access to primary PCI for STEMI patients has been established.  
However, there are significant barriers to the establishment and implementation of the ideal 
system.  One possible limitation is the unstructured and competitive nature of the United States 
healthcare system.  Due to this lack of structure other possible barriers to the implementation of a 
coordinated system of care subsequently arise.  For example, the heterogeneous nature of EMS 
providers and hospitals across the U.S. will require that these “systems” be malleable enough to 
account for the differences in local needs and the resources of different communities.  
Limitations 
This review has several limitations.  All of the studies had an observational pre/post 
design, which can prevent the establishment of a causal relationship between implementation of 
a STEMI network and the frequency and timeliness of diagnostic and therapeutic coronary 
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interventions and patient outcomes such as morbidity, mortality, and hospital length of stay.  The 
before-and-after design of the studies may also subject the differences found between patients in 
the pre- and post- implementation groups to confounding factors that may occur with temporal 
changes. 
Another limitation of creating coordinated STEMI networks throughout a region is one 
that stems from economics.  In a great number of hospitals, cardiovascular services make up 
close to 40 percent of general revenue and in turn those services are used to subsidize other less 
profitable, yet important services (Nallamothu et al., 2007b).  By taking STEMI patients from 
smaller hospitals to larger PCI-capable hospitals, there needs to be consideration given to the 
possible change in revenue and reimbursement structures for these smaller hospitals.  Therefore, 
when designing STEMI systems of care there needs to be careful thought given as well as 
changing reimbursement structures proposed.  This is a necessary consideration in order to avoid 
the significant pressures from referring hospitals to keep and give care for patients with STEMIs 
when they should instead be sent out to a STEMI receiving center in order to provide the best 
care possible to the patient. 
Finally, another challenge occurs in regard to the public’s use of EMS.  That is, patients 
who are transported via EMS have two advantages when treated within a STEMI system of care 
which are 1) they may have shorter times to reperfusion therapy because of an earlier and more 
prompt recognition of their symptoms, and 2) they may be transported  directly to a primary PCI 
center if a pre-hospital EKG was performed.  That is, EMS providers may pass by a smaller 
hospital without stopping there because the providers are aware the patient is having a STEMI 
based on the pre-hospital EKG.  The EMS providers will instead head straight to a PCI-capable 
hospital with the knowledge that the patient will receive more appropriate care at the PCI-
19 
 
capable hospital.  This in turn will avoid a probable transfer, which will consequently save time 
and therefore save heart muscle. 
Implications for Future Research 
Evidence suggests that primary PCI is the preferred reperfusion strategy in the majority of 
patients with a STEMI.  However, a minority of patients is treated with primary PCI and even 
fewer of those are treated in the recommended 90 minutes after first medical contact.  The 
benefits of primary PCI are the greatest if the procedure is performed in a timely manner after 
initial symptom onset (Keeley, Boura, & Grines, 2003). 
The literature presented supports the development and implementation of a highly 
coordinated system of care.  However, this will require a practice change in many institutions, 
and it is important to realize that attempting to change practice can be a challenging task.  
Therefore, implementing these strategies will require a carefully planned educational 
intervention for ER physicians, interventional physicians, EMS providers, staff RNs, and 
hospital administration, and a plan to increase buy-in from staff.  Educational interventions 
should be designed to raise awareness of what a STEMI is, what the process is once the STEMI 
is diagnosed, and what is the best practice (i.e., core measures for AMI) in treating a STEMI 
patient by staff RNs.  
Implications for Practice 
 Collectively, data from the reviewed studies support the implementation of a STEMI 
network, or an organized system of STEMI care to facilitate the delivery of care to patients who 
present with STEMIs and in order to improve patient outcomes.  Implementation of a STEMI 
network may increase the frequency, timeliness, and appropriateness of diagnostic and 
therapeutic coronary interventions.  Patients with STEMIs who have received care within a 
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STEMI network or an organized system of care have benefitted from its association with a 
decreased D2B time and subsequent decrease in morbidity and mortality.  Quality improvement 
efforts that target the dissemination and adoption of an organized system of care for patients with 
STEMIs among clinicians should continue. 
Conclusion 
Improving outcomes for patients who present with a STEMI in the United States is an 
important public health goal.  Although these studies are a part of a small but growing body of 
literature, they all demonstrate the potential of a streamlined and coordinated process in treating 
STEMI patients.  The optimization of care of STEMI patients through the establishment of 
systems of care could be of great value.  If these systems can be implemented correctly (i.e., 
accounting for differences in regional needs), such coordinated care systems have the potential to 
significantly improve outcomes for these patients.  This is critical because acute myocardial 
infarction (STEMI) is still the leading cause of death in the United States and worldwide (CDC, 
2014).  All of the studies presented in this integrative review of the literature demonstrate the 
effectiveness of a quality improvement strategies that are directed towards the processes of care 
of STEMI patients from a variety of different regions (i.e., rural, urban, etc.).  Ultimately, a well-
designed and coordinated system of care, created using the existing evidence, will improve care 
for patients with a STEMI. 
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Table 1: Articles Utilized in Review. 
EMS STEMI Articles 
Citation  Focus of Study Method/ 
Design 
Sample Findings Conclusion/ 
Recommendations 
Cone et 
al., 
(2013) 
To examine D2B 
times and 
compliance with 
the national 90-
minute D2B 
performance 
benchmark in 
the first 14 
months of a 
“field activation 
protocol” 
Quasi-
experimental. 
Prospective, 
observational 
There were 
38 EMS field 
activations, 
47 
nonactivatio
n EMS 
STEMI 
arrivals, and 
28 walk-in 
STEMI 
patients 
The mean (±SD) D2B 
times were 37 (±17), 
87 (±40), and 80 (±23) 
minutes, respectively. 
D2B time was better 
for the EMS field 
activations than for 
either nonactivation 
EMS transports or 
walk-in patients 
Compliance with the 
90-minute D2B 
benchmark was 100%, 
72%, and 68%, 
respectively, and was 
better for the EMS field 
activations than for 
either of the other 
groups. 
EMS field activation of the cath lab 
for patients with a STEMI is 
associated with shorter D2B times 
and better compliance with 90-
minute benchmarks than ED 
activation for either walk-in STEMI 
patients or STEMI patients arriving 
by EMS without field activation. 
However, improvements are 
needed with the compliance in the 
field activation protocol to 
maximize the stated benefits.  
  
27 
 
Table 1 (continued) 
 
Citation  Focus of Study Method/ 
Design 
Sample Findings Conclusion/ 
Recommendations 
Fosbol et 
al., 
(2013)  
To assess the 
adherence of 
EMS to a 
STEMI protocol 
developed in 
NC. 
Quasi-
experimental
.   
 Patients were 
divided into 1) 
transported 
directly to a PCI 
hospital, 2) first 
taken to a 
closer non-PCI 
center and later 
transferred to a 
PCI hospital. N 
= 6,010 patients 
with STEMI, 
1288 were 
eligible. Of 
these, 826 
(64%) were 
transported 
directly to a PCI 
facility, 
whereas 462 
(36%) were first 
taken to a non-
PCI hospital and 
later 
transferred. 
In the author’s 
multivariable model, 
increase in differential 
driving time and 
cardiac arrest were 
associated with a 
lesser likelihood of 
being taken directly to 
a PCI center, whereas 
a history of PCI was 
associated with a 
higher likelihood of 
being taken directly to 
a PCI center. Patients 
sent directly to a PCI 
center were more 
likely to have times 
between first medical 
contact and PCI within 
guideline 
recommendations  
It was determined that patients 
who were sent directly to a PCI 
center had significantly shorter 
time to reperfusion. The 
prehospital EMS approach was 
associated with faster reperfusion 
times and  greater likelihood of 
meeting STEMI treatment 
guidelines. 
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Table 1 (continued) 
 
Citation  Focus of Study Method/ 
Design 
Sample Findings Conclusion/ 
Recommendations 
Eckstein 
et al., 
(2009)  
To determine 
the 
performance 
of a regional 
system with 
prehospital 12-
lead EKG 
identification 
of STEMI 
patients and 
direct 
paramedic 
transport to 
STEMI 
receiving 
centers for PCI. 
Prospective 
observationa
l cohort 
study 
1,220 patients 
in Los Angeles 
who were 
identified with 
suspected 
STEMI on 
prehospital 12-
lead.  
60% underwent 
emergency PCI. A D2B 
time of 90 minutes or 
less was achieved for 651 
(89%) patients, and 459 
(62.5%) had EMS-patient 
contact-to-balloon times 
</= 90 minutes. 
Transport of suspected 
STEMI patients to an 
STEMI Receiving Center 
(SRC) resulted in 
ambulance diversion 
from a closer ED for 31% 
of patients and a median 
increase in transport 
time of 3.8 minutes. 
D2B times within the 90-minute 
benchmark were achieved for 
nearly 90% of STEMI patients 
who were transported by 
paramedics after implementing 
a regional system. Whereas the 
national average of STEMI 
patients who are taken for 
primary PCI have a D2B time of 
less than 90 minutes is only 4%. 
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Table 1 (continued) 
 
Citation  Focus of Study Method/ 
Design 
Sample Findings Conclusion/ 
Recommendations 
Caudle et 
al., 
(2009)  
Purpose: 
assess the 
effectiveness 
of a protocol 
for rapid 
access to PCI in 
reducing D2B 
times in 
STEMI. 
Descriptive 
pre-post-
program 
evaluation. 
Rapid transport 
protocol n=39, 
historical 
controls n=42 
Patients transported 
under the rapid access 
protocol (n = 39) were 
compared with historical 
controls (n = 42). Median 
D2B time was reduced 
from 87 minutes (67-
108) pre-protocol to 62 
minutes (40-80) post-
protocol (p < 0.001). 
The implementation of an EMS 
protocol for rapid access to PCI 
significantly reduced time to 
reperfusion for patients with 
STEMI. 
  
30 
 
Table 1 (continued) 
 
Citation  Focus of 
Study 
Method/ 
Design 
Sample Findings Conclusion/ 
Recommendations 
Cheskes 
et al., 
(2011)  
Purpose: to 
determine the 
proportion of 
patients who 
met the 
benchmark of 
first 
emergency 
contact to 
balloon (E2B) 
in less than 90 
minutes after 
institution of 
a regional 
paramedic 
activated 
STEMI bypass 
to primary PCI 
protocol. 
Pre/post 
observation 
cohort 
study over a 
24-month 
period 
Included were all 
patients diagnosed 
with STEMI by 
paramedics trained in 
ECG acquisition/ 
interpretation and 
transported via EMS. 
In the "pre" phase of 
the study, 
paramedics gave EDs 
advance notification 
of the arrival of 
STEMI patients and 
took the patients to 
the ED of the PCI 
center. In the "post" 
phase of the study, 
paramedics activated 
a STEMI bypass 
protocol in which 
STEMI patients were 
transported directly 
to the PCI suite, 
bypassing the local 
hospital EDs.  
The times for 95 STEMI 
patients in the pre- 
phase were compared 
with the times for 80 
STEMI patients in the 
post phase. The 
proportion for whom 
D2B was less than 90 
minutes increased from 
28.4% before to 91.3% 
after (p < 0.001). 
Median E2B time 
decreased from 107 
minutes pre to 70 
minutes post. Median 
D2B time decreased 
from 83 minutes pre to 
35 minutes post. 
Median E2D time 
increased from 21 
minutes pre to 32 
minutes post. Median 
differences between 
phases were significant 
at p < 0.001.  
The proportion of patients 
with E2B times less than 90 
minutes significantly 
improved through with the 
implementation of this 
paramedic-activated STEMI 
bypass protocol. Further 
study should occur to 
determine whether the 
benefits are reproducible in 
other EMS systems. 
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Table 1 (continued) 
 
Citation  Focus of 
Study 
Method/ 
Design 
Sample Findings Conclusion/ 
Recommendations 
Camp-
Rogers et 
al., 
(2011)  
Evaluating the 
accuracy of 
EMS 
activation of 
the cardiac 
cath lab for 
patients with 
STEMI and its 
impact on 
treatment 
intervals from 
dispatch to 
reperfusion. 
Pre/post 
retrospectiv
e cohort 
study 
A total of 53 patients, 
14 before and 39 
after prehospital 
activation, were 
included 
EMS cardiac cath lab 
activation was 79.6% 
sensitive and 99.7% 
specific. Mean door-to-
hospital EKG and mean 
cath lab-to-reperfusion 
times were not affected 
by the intervention. 
Prehospital activation of 
the cath lab significantly 
improved mean door-
to-balloon (D2B) time 
by 18.2 minutes and 
door-to-cath lab by 14.8 
minutes. Improvements 
in D2B were 
independent of 
presentation during 
peak hours. There were 
significant time savings 
reflected in all EMS 
intervals.  
Emergency medical service 
providers can appropriately 
activate the CCL for patients 
with STEMI before 
emergency department 
arrival, significantly reducing 
mean D2B time. Significant 
reduction is demonstrated 
throughout EMS intervals. 
  
32 
 
Table 1 (continued) 
 
Process Flow STEMI Articles 
Citation  Focus of Study Method
/ Design 
Sample Findings Conclusion/ 
Recommendations 
Clark et 
al., 
(2012)  
Assessing the 
relationship of 
emergency 
medical 
services (EMS) 
intervals and 
internal 
hospital 
intervals to the 
rapid 
reperfusion of 
patients with 
STEMI. 
Seconda
ry 
analysis 
of 
prospect
ive 
cohort. 
313 EMS-
transported 
STEMI 
patients with 
298 (95.2%) 
MI team 
activations. 
between 
January 1, 
2004, and 
December 31, 
2009. 
In a multivariate analysis, hospital 
processes EMS activation and Lab 
arrival to Reperfusion were the most 
important predictors of Scene to 
Balloon ≤ 90 minutes. 
In this study, hospital 
process intervals (i.e., EMS 
activation, door to page, 
page to laboratory, and 
laboratory to reperfusion) 
are key covariates of rapid 
reperfusion for EMS STEMI 
patients and should be 
used when assessing 
STEMI care. 
Kalla et 
al., 
(2006) 
The purpose of 
this study was 
to determine 
whether 
implementation 
of recent 
guidelines 
improves in-
hospital 
mortality from 
acute STEMI in 
a metropolitan 
area. 
Pre/post 
retrospe
ctive  
1053 patients 
who were 
admitted with 
acute STEMI 
to 1 of the 5 
participating 
high 
frequency 
cardiology 
departments.  
Demonstrated the number of 
patients receiving 1 of the 2 
reperfusion strategies (from 66% to 
86.6%). Conversely, the proportion 
of patients not receiving reperfusion 
therapy dropped from 34% to 13.4%, 
respectively. Primary PCI (PPCI) 
usage increased from 16% to almost 
60%, whereas the use of lytics 
decreased from 50.5% to 26.7% in 
the participating centers. PPCI was 
more effective in acute STEMI of > 3 
but < 12 hours' duration. 
The implementation of 
recent guidelines for the 
treatment of acute STEMI 
by the organization of a 
cooperating network 
within a large 
metropolitan area was 
associated with a 
significant improvement in 
clinical outcomes. 
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Table 1 (continued) 
 
Citation  Focus of Study Method
/ Design 
Sample Findings Conclusion/ 
Recommendations 
Saia et 
al., 
(2009)  
To assess the 
clinical impact 
of a regional 
network for the 
treatment 
STEMI. 
Pre/post 
compari
son 
All patients 
with STEMI (n 
= 1823) 
admitted to 
any of the 
hospitals of 
an area with 
one million 
inhabitants 
during the 
year 2002 (n = 
858)-that is, 
before the 
network was 
implemented, 
and in 2004 (n 
= 965), the 
year of full 
implementati
on of the 
network, 
were enrolled 
in this study 
Between 2002 and 2004, there was a 
major change in reperfusion 
strategy: primary angioplasty 
increased from 20.2% to 65.6%, 
fibrinolytic therapy decreased from 
38.2% to 10.7% and the rate of 
patients not undergoing reperfusion 
was reduced from 41.6% to 23.7%. 
In-hospital mortality decreased from 
17.0% to 12.3%. This reduction was 
continued at 1-year follow-up.  The 
1-year incidence of all major adverse 
cardiac and cerebrovascular events 
were reduced from 39.5% in 2002 to 
34.3% in 2004. 
Organization of a network 
for treatment of STEMIs is 
associated with increased 
rates of reperfusion 
therapy and reduction of 
in-hospital and 1-year 
mortality. 
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Table 1 (continued) 
 
Citation  Focus of Study Method
/ Design 
Sample Findings Conclusion/ 
Recommendations 
Pan et 
al., 
(2014) 
Purpose: was to 
assess D2B time 
before and 
after specific 
hospital 
strategies, 
including a 
computerized 
provider order 
entry (CPOE), 
were 
implemented to 
reduce D2B 
time. 
Retrosp
ective 
cohort 
study 
A total of 134 
patients were 
included in 
the study 
(preinterventi
on, n = 69; 
postinterventi
on, n = 65). 
Median D2B time improved from 83 
to 63 min after the new strategies 
were implemented ( P = 0.001). 
Median door-to-electrocardiogram 
(5-2 min) and door-to-laboratory 
time (60-41 min) also significantly 
improved ( P < 0.001). The 
proportion of patients with a D2B 
time within 90 min increased from 
59.4 % to 98.5 % ( P < 0.001). 
These findings suggest that 
implementing specific 
strategies can substantially 
improve D2B time for 
patients with STEMI and 
increase the proportion of 
patients with D2B time less 
than 90 min. 
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Table 1 (continued) 
 
Citation  Focus of Study Method
/ Design 
Sample Findings Conclusion/ 
Recommendations 
Bajaj et 
al., 
(2012)  
Purpose: was to 
determine the 
impact of 
emergency 
physician-
activated “Code 
STEMI” 
protocol on 
door-to-balloon 
times during 
off-hours. The 
primary 
objective was 
to compare 
median D2B 
times in both 
the study 
groups 
Pre/post 
compari
son 
Two study 
groups: one 
group 
consisted of 
27 STEMI 
patients who 
presented 
during off-
hours in the 
pre-Code 
STEMI period 
(Jan to Dec 
2006) and the 
second group 
consisted of 
60 STEMI 
patients 
admitted 
during off-
hours when 
Code STEMI 
was fully 
operational 
(Jan 2007 to 
Dec 2008). 
With the implementation of “Code 
STEMI” protocol, the median D2B 
time during off-hours dropped to 77 
min (interquartile range [IQR] 67–
95), representing a 52-min 
improvement (p = 0.0001). ECG-to-
catheterization laboratory time 
demonstrated absolute reduction of 
16 min. Median peak troponin-I 
levels dropped from 62 ng/mL (IQR 
23–142) to 25 ng/mL (IQR 7–43; p < 
0.002). No statistically significant 
differences were perceived in all-
cause mortality among the study 
groups. 
Implementation of “Code 
STEMI” protocol at this 
institution significantly 
reduced D2B times for 
STEMI during off-hours. 
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Table 1 (continued) 
 
Citation  Focus of Study Method
/ Design 
Sample Findings Conclusion/ 
Recommendations 
Reimer 
et al., 
(2013)  
Purpose: was to 
evaluate the 
effectiveness of 
a streamlined 
interfacility 
referral 
protocol in 
reducing door-
to-balloon 
(D2B) times for 
patients 
experiencing 
acute STEMI. 
Retrosp
ective 
databas
e review 
A total of 133 
patients 
exhibited 
complete 
data and 
were included 
in the 
analysis, 54 of 
which were 
transferred 
via the 
streamlined 
referral 
protocol 
Streamlined referral patients 
exhibited a median D2B time of 101 
minutes vs a median D2B time of 122 
minutes for the traditional referral. 
D2B times of 90 minutes or less were 
achieved in 13% of the traditional 
referral patients and in 30% of the 
protocol group. 
The implementation of a 
streamlined referral 
protocol has significantly 
reduced D2B times for 
patients diagnosed with 
STEMI that required 
interfacility transport for 
intervention. 
Niles et 
al., 
(2010) 
Purpose: 
Compare pre 
and post 
strategy 
implementation 
for process 
improvement of 
STEMI patients’ 
D2B times.  
Pre/post 
compari
son 
Series of 
STEMI 
patients 
presenting 
pre and post 
strategy 
implementati
on.  
Significant reductions in time to first 
ECG in the emergency department 
and D2B were seen in group 2 
compared with group 1. 
Important improvement in 
the process of acute STEMI 
patient care was 
accomplished in the rural 
percutaneous coronary 
intervention center setting 
by implementing evidence-
based strategies. 
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Table 1 (continued) 
 
Citation  Focus of Study Method/ 
Design 
Sample Findings Conclusion/ 
Recommendations 
Kelly et al., 
(2010)  
Purpose: To 
evaluate whether 
or not Six Sigma 
methodology was 
successful in 
helping to decrease 
D2B times. 
Pre/post 
comparison 
Outcomes 
were tracked 
over time and 
was used for 
the 
comparison of 
all STEMI 
patients who 
presented to 
Wake Forest 
Hospital. 
After process analysis 
and implementation of 
improvements, mean 
D2B times decreased 
from 128 to 90 minutes. 
Improvement has been 
sustained; as of June 
2010, the mean D2B 
was 56 minutes, with 
100% of patients 
meeting the 90-minute 
window for the year. 
Six Sigma methodology and 
immediate provider feedback 
result in significant reductions 
in D2B times. The lessons 
learned may be extrapolated 
to other primary percutaneous 
coronary intervention centers 
Ahmar et 
al., (2008)  
Purpose: assess the 
hospital practice 
for managing acute 
STEMI by 
identifying 
processes 
associated with 
time delays and 
instrument changes 
to acute STEMI 
management 
protocol. 
Pre/post 
comparison 
Consecutive 
patients 
presenting 
with STEMI 
from 4/2005-
9/2005 and 
from 4/2006-
9/2006. 
This study revealed 
through ongoing review 
through a quality 
improvement program 
improves D2B times. 
This is integral to the 
optimal management of 
patients with acute 
STEMI who are treated 
with PCI. 
Implications from this study 
suggest that a coordinated 
approach with ongoing review 
through a quality 
improvement program is 
critical in reducing the D2B 
times in STEMI patients. 
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Table 2: EMS Articles 
Field Activation Direct Transport 
Cone et al., (2013) Fosbol et al., (2013) 
  
Cheskes et al., (2011) Eckstein et al., (2009) 
  
Camp-Rogers et al., (2011) Caudle et al., (2009) 
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Table 3: Hospital Process Articles. 
Code STEMI/Code AMI Hospital Specific 
Process Changes 
STEMI Networks/ 
Regionalizations 
Data Feedback 
Bajaj et al., 2012  Pan, et al., 2014 Kalla, et al., 2006  Kelly, et al., 2010  
    
Ahmar, et al., 2008 Niles, et al., 2010 Saia, et al., 2009  Niles, et al., 
2010 
    
 Ahmar, et al., 2008  
 
Reimer, et al., 2013  
 Clark, et al., 2012   
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Abstract 
Purpose: The purpose of this project was to evaluate the implementation of an ST-elevation 
myocardial infarction (STEMI) Network into a large metropolitan healthcare system in 
Kentucky.  The objectives of this project were to (1) determine if (and to what extent) the 
implementation of the STEMI Network decreased walk-in, emergency medical services (EMS), 
and transfer door to balloon (D2B) times at a STEMI receiving center at a metropolitan 
Kentucky academic hospital, (2) determine if there is a difference in treatment times for those 
individuals who present during working hours compared to non-working hours of the day, and 
(3) examine the associations between STEMI processes and specific patient characteristics (age, 
gender, race, body mass index, and various co-morbidities). 
Setting: This project was conducted in an in-hospital invasive cardiovascular laboratory at a 
large metropolitan tertiary care and multi-organ transplant center located in Kentucky.  
Population: Among the sample 69.9 % were male and 30.1 % were female. 80.1 % of the 
sample was Caucasian and 17.9 % were African American.  Those included had an average age 
of 59 years (SD= 13.8), the mean body mass index (BMI) was 29.0% (SD=7.5), and 65.5% 
percent presented during non-working hours, while 34.5 % presented during working hours. 
Inclusion criteria: Patients 18 years or older with the principal diagnosis of a STEMI who 
presented as a walk-in to the ED, via EMS directly to the receiving facility or as a transfer 
patient from one of the referring hospitals within a 35 mile radius of the receiving hospital during 
three separate time periods. 
Design & Methods: A retrospective study of electronic medical record data was conducted to 
evaluate the efficacy of a STEMI Network during three separate four consecutive month long 
time frames.  ICD-9 codes 410.0-410.9 and medical record numbers were obtained by the 
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Information Technology Department at a large metropolitan hospital in Kentucky.  The data 
review included age, gender, race, height, weight; history of hypertension, diabetes mellitus, 
prior MI; zip code of patient presenting via EMS; FMC time, door time, first medical contact 
time, EKG time, cardiac catheterization lab door time, and device time, and time of day 
categorized into working and non-working hours.  
Results: When examining the comparison between the two cohorts pre-implementation (n=32) 
versus post-implementation (n=82) the overall mean D2B time dropped from a pre-
implementation mean time of 136.3 minutes to 80.5 minutes (log p-value = .005).  The 
interaction between D2B times and pre/post cohort group was statistically significant with a p-
value = .017.  Walk-in and transfer patients all had D2B times that decreased when comparing 
pre to post-implementation D2B times.  While EMS patients did not show a statistically 
significant decrease in times, there was still a decrease from mean of 85 minutes to a mean of 76 
minutes with those patients exhibiting the lowest overall D2B times.  Furthermore, patients who 
presented during non-working hours (pre-implementation log mean time of 202 minutes and a 
post-implementation log mean time of 88 minutes) and as transfers (pre-implementation log 
mean time of 238.6 minutes and post-implementation log mean time of 88.8 minutes) seemed to 
have the greatest benefits of the STEMI Network. 
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Introduction 
Coronary heart disease (CHD) is the principal cause of death in adults throughout the 
world and accounts for an even more substantial number of deaths in developed countries 
(Rosamond, Flegal, & Friday, et al. 2007).  According to Murphy, Xu, and Kochanek (2013), 
approximately 600,000 people die from heart disease in the United States every year.  Moreover, 
heart disease is the leading cause of death for both males and females.  The most common type 
of heart disease is coronary artery disease, which kills nearly 380,000 people annually (Murphy, 
Xu, & Kochanek, 2013).  Every year in the United States approximately 720,000 individuals 
have a heart attack, of those nearly 75 percent are considered a first heart attack for the 
individual (Go, Mozaffarian, Roger, et al, 2014).  Additionally, CVD costs the United States 
320.1 in 2011 and more specifically, CHD costs the United States practically $108.9 billion a 
year (CDC, 2015).  This estimation includes the cost of the healthcare provided to patients, their 
necessary medications, and the loss of productivity associated with the illness (Heidenreich, 
Trogdon, Khavjou et al., 2011). 
The burden of heart disease not only exists as a national problem, it also is a significant 
burden in the Commonwealth of Kentucky.  According to Rosamond, Flegal, & Friday, et al. 
(2007), Kentucky was ranked sixth highest in total cardiovascular disease (CVD) deaths.  
Moreover, the morbidity and mortality from CVD in Kentucky are among the highest in the 
United States (KDPH, 2004).  Nationally, Kentuckians have the some of the highest prevalence 
of multiple risk factors at 46 percent of adults (e.g., cholesterol, smoking, sedentary lifestyle, 
obesity, etc.) (CDC, 2015).  This data suggest there is much to be done in the Commonwealth of 
Kentucky to decrease the incidence and prevalence as well as mortality and morbidity of 
coronary artery disease.   
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Background 
Coronary artery disease carries the risk of acute coronary syndromes.  Acute coronary 
syndrome is an umbrella term that can include any of the three following more specific 
syndromes; unstable angina, non-ST segment myocardial infarction or a heart attack (NSTEMI), 
and ST-segment elevation myocardial infarction or heart attack (STEMI).  All three of these 
terms are associated with a sudden rupture of plaque inside the coronary artery.  It is the location 
of the blockage, the amount of time in which the blood flow to the myocardium (i.e., heart 
muscle) is occluded, and the amount of damage that determines which type of acute coronary 
syndrome is occurring (Cleveland Clinic, 2015).  The type of acute coronary syndrome that is 
termed STEMI is the type of heart attack that is associated with a large area of the myocardium; 
therefore there will be changes on the EKG, which manifest as ST elevations, thus STEMI.  A 
STEMI is a medical emergency and requires prompt and timely treatment in order to save as 
much heart muscle as possible.  The American College of Cardiology (ACC), the American 
Heart Association (AHA) as well as the European Society of Cardiology recommends 
percutaneous coronary intervention (PCI) as the preferred method of reperfusion for STEMI 
patients (Antman et al., 2004; Van de Werf et al., 2003).  However, current evidence suggests 
that a major limitation to timely reperfusion of STEMIs in the United States is access and lack of 
an organized system of care (Nallamothu et al., 2006; Jacobs et al., 2006). 
Door to balloon time (D2B) is the time from the arrival of an STEMI patient at a hospital 
to the time of PCI.  This is a critical variable when evaluating the outcomes of STEMI patients 
treated with PCI (McNamara et al., 2006).  The ACC/AHA, the Joint Commission Core 
Measures, and the European Society of Cardiology published the current recommended door to 
balloon (D2B) time as being within a 90 minute time frame (Antman et al, 2008; Silber et al., 
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2005; Antman, Hand, & Armstrong, 2008) and within a 120 minute timeframe for transfer 
patients (ACC/AHA guidelines in 2002).  The relationship between decreased 
morbidity/mortality and door to balloon (D2B) time is supported by multiple other studies that 
also suggest a continuous relationship between shorter D2B times and better survival for patients 
who undergo primary PCI for a STEMI (Antonuicci et al, 2002; Berger et al, 1999; Cannon et al, 
2000; McNamara et al, 2006; Brodie et al, 2001).  For every 15 minute time period beyond 90 
minutes there is an associated increased risk of in-hospital death from complications 
(Nallamothu, Bradley, & Krumholz, 2007).  Despite this widespread knowledge, the vast 
majority of these individuals, both male and female, fail to receive the appropriate treatment for 
this life-threatening condition within the recommended timeframes.     
It is for these reasons, as well as the desire to provide patients with the best care possible 
that the STEMI Network was developed at a large metropolitan academic tertiary hospital in 
Kentucky.  The purpose of the STEMI Network is to decrease D2B times by the optimization of 
patient flow (i.e., movement from the field, en route with EMS, through the ER, to the cardiac 
catheterization lab (cath lab), with cath lab call team staff prepared and ready for the emergency 
patient) and procedural characteristics so that a decreased D2B time can be obtained thereby 
decreasing the time until a blocked artery is opened in the cath lab.  The goal of the STEMI 
Network is to decrease door or first medical contact (FMC)-to-balloon (D2B) to 90 minutes or 
less.  Furthermore, the goal of the STEMI Network is to decrease D2B time to the lowest 
possible D2B time.  The ways in which the STEMI Network will aim to achieve an improvement 
in this time are threefold: (1) provide immediate assessment in the field, which will allow the 
patient to skip the initial emergency department (ED) assessment and be transported directly to 
the cath lab; (2) eliminate the timely process of unloading patients at a local hospital that is non-
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PCI capable; and (3) provide continuous feedback and education on the process and importance 
of timely treatment and care of STEMI patients to staff involved.  All of these aforementioned 
items address the optimization in the flow of the patient from the field through the ED to the cath 
lab throughout the cardiac catheterization procedure until PCI is completed.  
Furthermore, in order to provide data feedback and assist in the self-reporting of process 
improvements the use of Six Sigma methodology is suggested.  Six Sigma methodology is a 
quality improvement tool that was first developed and used by the Motorola Corporation in the 
1970s (Harry, 2000).  This is an evaluation tool that has more recently been adapted to use in the 
medical field in order to attempt to create less error and to increase efficiency (Schweikhart, 
2009).  Specifically, Six Sigma can be useful in the analysis and subsequent modifications to 
complicated and time sensitive processes that are multidisciplinary in nature and to a variety of 
treatment areas (e.g., EMS, ED, cath lab) (Kelly et al., 2010).  Consequently, this tool is 
particularly useful in exploring any issues with the rapid reperfusion of patients who present with 
a STEMI. 
Purpose of the Study 
The purpose of this study was to evaluate the impact of the implementation of a STEMI 
Network into a large metropolitan healthcare system.  This study will look to explore whether the 
implementation of the STEMI Network decreased the time in which STEMI patients were 
appropriately treated with PCI as the primary form of reperfusion therapy in less than 90 minutes 
for walk-in and EMS patients; and 120 minutes for transfer patients.  The specific aims of this 
retrospective medical record review were to examine if: 1) the implementation of a STEMI 
Network decrease walk-in door to balloon (D2B) times, 2) the implementation of a STEMI 
Network decrease emergency medical system (EMS) D2B times, 3) the implementation of a 
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STEMI Network decrease the D2B time of patients transported from satellite hospitals within a 
35 mile radius of the metropolitan hospital (i.e., transfer patients), and 4) to examine whether or 
not there an association between the time of day (working hours versus non-working hours) 
when the patient was admitted and D2B times? 
Description of the Practice Inquiry Project 
 This practice inquiry project involved the evaluation of selected outcomes of the STEMI 
Network in patients who present via walk-in or EMS or are transferred to a 462-bed tertiary 
referral center and multi-organ transplant center located in a metropolitan region of Kentucky.  A 
(descriptive and retrospective review of the EMR) one-time series pre/post-test analysis was used 
to determine specific outcomes of the implementation of the STEMI Network and its ability to 
decrease the D2B times of STEMI patients. 
Methods 
Study Design and Sample 
A retrospective medical record review was conducted for this descriptive study.  One 
hundred fifty six medical records from patients who were admitted to a metropolitan hospital 
were selected for review.  Subjects included all patients admitted to the receiving hospital whose 
principal diagnosis was a STEMI during three separate time frames. The first time frame will be 
considered the STEMI Network pre-implementation time period and will range from June 1, 
2012 through September 30, 2012.  The second and third time periods will be considered the 
STEMI Network post-implementation time frame and will range from June 1, 2013 through 
September 30, 2013 and June 1, 2014 through September 30, 2014.  Inclusion criteria are all 
patients 18 years or older with the principal diagnosis of a STEMI who presented as a walk-in to 
the ED, via EMS directly to the hospital’s ED, or as a transfer patient from one of the referring 
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hospitals within a 35 mile radius of the receiving hospital during the time periods of June 1, 2012 
through September 30, 2012, from June 1, 2013 through September 30, 2013, and from June 1, 
2014 through September 30, 2014.  Exclusion criteria include the following: patient age under 18 
years, patients who expire prior to percutaneous coronary intervention, transfers who are coming 
to the metropolitan hospital from greater than 35 miles distance, and patients who have received 
fibrinolytics before transfer or admission.  A waiver of authorization will be requested from the 
IRB (Appendix A). 
Setting 
An in-hospital cardiac catheterization laboratory at a 462-bed metropolitan tertiary care 
referral center in Kentucky was used as the setting for this study.  The hospital is accredited by 
the Joint Commission for Accreditation of Hospitals.  
Procedure    
Following the development of a project proposal and authorization from the capstone 
committee, approval was obtained from the facility’s nursing research council (Appendix B).  An 
expedited proposal was then submitted and subsequently approved by the University of 
Louisville’s (U of L) Institutional Review Board (IRB) (Appendix C).  Following U of L’s 
approval an IRB authorization agreement (IAA) form was then submitted to request approval 
from the University of Kentucky’s (UK) IRB (Appendix D).  Nurse administrators, service line 
directors, the director of invasive cardiology, and the chest pain coordinator were informed of the 
project via hospital email communication and scheduled face-to-face meetings.  Approval was 
obtained from the director of the cardiovascular service line (Appendix E).  This research 
involved minimal risk to the participants. 
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Data was retrospectively collected by the Primary Investigator (PI) from multiple 
electronic medical databases (EMRs) (Sovera, ICIP, Clinician Valet, Cerner).  Data was securely 
stored in a locked file while in paper form (Data Collection Form, Appendix F) in which the PI 
assigned each subject a sequential ID number.  Once all data was collected and there was no 
further need to return to a subject’s medical record, paper forms were then shredded.  The data 
was transferred to an SPSS spreadsheet once received.  Data was secured electronically on the 
PI’s password protected computer in a locked office.  The code to the computer was available to 
the PI only.  Data was stored on an encrypted file on password protected computers.  Data was 
not stored on an unauthorized “cloud” type server per HIPAA regulations. 
Data Collection 
Demographic and data collection variables for this study were collected from the 
following databases of the EMR (Sovera, ICIP, Clinician Valet, Cerner): age, gender, race, 
height, weight, zip code of patient presenting via EMS, and name of satellite facility of origin or 
referring hospital of origin (within a 35 mile radius of the receiving hospital).  Independent 
variables of interest were collected from the various databases of the EMR (Sovera, ICIP, 
Clinician Valet, Cerner): principal diagnoses and comorbidities that included: history of 
hypertension, dyslipidemia, diabetes mellitus (diet controlled, insulin requiring, non-insulin 
requiring, or no treatment), prior myocardial infarction (MI), prior percutaneous coronary 
intervention, prior coronary artery bypass graft surgery (CABG), cocaine use, smoking status, 
cardiogenic shock on arrival, hemoglobin A1C, HDL, LDL, cholesterol, statin therapy, non-
statin lipid lowering therapy, name of satellite facility of origin or referring hospital of origin 
(within a 35 mile radius of the receiving hospital), first medical contact (FMC) time, door time, 
EKG time, STEMI EKG time, fibrinolytic time, cath lab staff activation time, cardiac cath lab 
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door time, device time, and time of day categorized into working hours of a business day  
(Monday-Friday, 0700-1700) and non-working hours of the day (weekends, holidays, and 1700-
0700, weekends, and holidays).  
Data Analysis     
Statistical analysis was performed using SPSS version 22.0 (SPSS Inc., Chicago, IL).  
Descriptive statistics were used to describe the sample.  Pre and post-implementation data were 
statistically analyzed using independent t-tests to assess mean scores prior to and following the 
STEMI Network implementation.  Additionally, statistical analyses included an ANOVA to 
discern any differences in mean D2B times for the analysis of continuous variables of pre-
implementation D2B and post-implementation D2B times.  Results of the statistical analyses will 
be considered statistically significant when p < 0.05.  A total of 156 medical records were 
reviewed for this study.  Forty-two records were ineligible for final D2B time analysis due to: (1) 
the administration of lytics prior to PCI or (2) no PCI conducted.  The remaining 114 records met 
criteria for inclusion and were considered eligible cases for the purpose of this study. 
Results 
Means, standard deviations, maximums and minimums for all study variables were 
calculated. These data are presented in Tables 1-3. 
Sample Description 
 During the three study periods 156 patients were admitted with a definite diagnosis of 
STEMI (n = 50 in 2012 (pre-implementation), n = 59 in 2013 (post-implementation), n = 47 in 
2014 (post), n = 106 total post).  Table 1 presents the descriptive data corresponding to patients’ 
demographics in pre, post, and overall categories.  Nearly 70% of the overall eligible cases were 
male and little more than 30% were female.  The patients had an overall mean age of 59 years 
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(SD = 13.7).  The percentage of Caucasians was 80.1%, African Americans totaled 17.9% 
overall, and Hispanics were just over 1% of total cases.  
 When comparing the two groups as categorized by pre-implementation and post-
implementation there was not a significant demographical difference between the two groups.  
Nearly 66% of the pre- group was male compared to almost 72% of the post- group being male.  
Females made up 34% of the pre-group while the post- group was made up of just over 28% 
females.  The patients in the pre-group had a mean age of 60 years (SD = 14.9) while the post- 
group had a mean age of 58 years (SD = 13.1).  The percentage of Caucasians in the pre- group 
was 74% while in the post- group 83% were Caucasian.  Interestingly, just over 39% of the pre- 
group were African American while in the post- group just over 60% were African American. 
 Tables 2 and 3 present data related to pre-existing and co-morbid conditions.  The most 
frequently occurring co-morbid conditions for the overall patient population were hypertension 
at 65.4%, positive smoking status at 53.2%, hyperlipidemia at 50.6%, non-insulin requiring 
diabetic at 19.2%, previous history MI 17.3%, previous history of PCI at 16.7%, previous history 
of CABG at 9.0%.  Additionally, there were no significant differences between pre/post cohorts 
in regard to laboratory data (Table 2).  Overall, the patients did significantly differ between the 2 
cohorts (pre/post) in the conditions of hypertension (p = 0.0017) and diabetes non-insulin 
requiring (p = 0.0445) (see Table 3).  The remaining co-morbidities and pre-existing conditions 
did not show any statistical significance. 
Main Study Analyses 
Overall Pre and Post D2B Times 
The current study was conducted to examine whether the implementation of a STEMI 
Network in a large metropolitan hospital would affect, either alone or interactively, the D2B time 
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of STEMI patients who presented either via walk-in, EMS, or transfer.  To test for these effects, 
an independent t-test was conducted (see Table 5).  Subjects were divided into pre-
implementation cohort (n = 32) and post-implementation cohort (n = 82).  Table 5 reveals that in 
the pre STEMI Network implementation cohort, the overall mean D2B time was 136.3 minutes 
(SD = 32.5) and post-implementation of the STEMI network, the overall mean D2B time 
dropped to 80.5 (SD = 26.9). The log p-value of 0.005 suggests that this decrease in D2B times 
was statistically significant.  Table 4 shows the rates of patient presentation separated by pre/post 
cohort. 
An ANOVA was conducted in order to take into account other variables and to explore 
the impact of a STEMI Network on D2B times.  The interaction between D2B times and pre/post 
cohort group was statistically significant, (F = 5.83, p = 0.017 when p < 0.05). 
Presentation Type and D2B Times 
EMS and D2B.  It should be noted that independent t-tests were initially conducted that 
revealed a skewed output (Table 5).  However, through the exploration of D2B and EMS 
presentation in the initial bivariate analysis, it was revealed that pre-implementation mean time 
was 85.5 minutes, (SD = 21.0, 61 min, 140 max) and post-implementation mean time was 76.9, 
(SD = 21.8, 46 min, 164 max, p = 0.14).  This suggests a not statistically significant interaction 
despite the fact that there was a decrease in mean times. 
Walk in and D2B.  Upon exploration of D2B times and walk-in presentation it was 
revealed that through a bivariate analysis that pre-implementation mean time was  98  minutes, 
(SD = 51, 62 min, 134 max) and post-implementation mean time was 86, (SD = 33, 54 min, 120 
max, p = 0.82).  This suggests a not statistically significant interaction despite the fact that there 
was a decrease in mean times. 
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Transfer and D2B.  Transfer patient presentation and D2B times were also examined in 
an independent t-test.  Data analysis revealed that pre-implementation mean time was 155 
minutes, (SD = 134, 86 min, 628 max) and post-implementation mean time was 92, (SD = 58, 55 
min, 474 max, p = 0.004).  This suggests a statistically significant interaction. 
 ANOVA. In regard to D2B time and all three types of presentation (walk-in, EMS, and 
transfer), Tables 5-7 present the data for the effects of STEMI Network implementation on D2B 
times.  Table 7 specifically presents an ANOVA that was conducted to determine whether a 
STEMI Network would have effects on D2B time when separated into categories based on 
presentation.  The results of this ANOVA revealed a highly significant effect. This suggests that 
there is in an interaction between implementation and presentation type (F = 6.17, p = .003).  
For this ANOVA, the log D2B times were taken for analysis because the initial analysis 
showed skewed D2B times.  The results of the ANOVA revealed for walk-in presentation pre-
implementation mean time was 98 minutes and post-implementation mean time was 78 minutes 
with a standard error of 72.6.  For EMS presentation pre-implementation mean was 72 minutes 
and post-implementation mean was 74 minutes.  Finally, transfer presentation pre-
implementation mean was 238 minutes and the post-implementation mean was 88 minutes.  
These changes in mean minutes for each type of presentation suggest that the impact of the 
implementation on D2B time seems to be the strongest for transfer patients from outlying 
hospitals.  
Working Versus Non-Working Hours D2B Times 
 Independent t-tests were conducted to explore the relationship between D2B and 
presentation during working hours in the pre/post cohorts.  It was revealed that pre-
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implementation mean time was 101.3 minutes and post-implementation mean time was 74.1 (log 
p-value = .007).  This suggests a statistically significant relationship. 
Independent t-tests were also conducted for patients who presented during non-working 
hours and explored D2B times between pre/post cohorts.  Through the bivariate analysis, it was 
revealed that pre-implementation mean time was 137.3 minutes and post-implementation mean 
time was 91.5 (log  p-value  = .051).  This suggests a not statistically significant interaction 
despite the fact that there was a decrease in mean times and the p-value was so close to p > .05 
(Table 6). 
Table 7 shows the results of the ANOVA which revealed whether there was an impact on 
D2B times based on the comparison between working hours (0700-1700) and non-working hours 
(1700-0700, weekends, and holidays).  The results suggest that no significant differences based 
on time or day of patient presentation existed (F = 2.94, p = .09).  When comparing pre- versus 
post-implementation D2B times, working hours pre-implementation D2B was a mean time of 70 
minutes with a standard error of 39.4, and post-implementation time was 72 minutes with a 
standard error of 34.6.  Conversely, non-working hours pre-implementation D2B revealed a 
mean of 202 minutes with a standard error of 38.8, while non-working hours post-
implementation mean was 88 minutes with a standard error of 26.3.  Because p = .09, and thus 
was approaching significance at p < .05, it was added to the  ANOVA to see if there was an 
interaction with pre/post implementation and whether or not there was a difference between 
patient presentation during working hours versus non-working hours.  This data analyses also 
revealed this to be not statistically significant.  
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Discussion 
 
 It should be understood that reducing total ischemic time has traditionally been limited to 
improving the D2B time for patients who present with a STEMI.  Within the D2B interval, the 
health care team can directly improve mortality by delivering rapid reperfusion therapy (Camp-
Rogers et al., 2011).  The current recommended door to balloon (D2B) time is within a 90 
minute time frame (Antman et al, 2008; Silber et al., 2005; Antman, Hand, & Armstrong, 2008).  
Despite this widespread knowledge, the majority of these STEMI patients do not receive 
appropriate treatment within the recommended timeframes.  With the creation of STEMI 
systems/networks of care, and subsequent ongoing improvements to these systems, the goal to 
reduce D2B times (and in turn, total ischemic time) has the possibility of being achieved. 
Based upon research previously conducted on the impact of STEMI Networks and their 
ability to decrease D2B times, the question was posed in this study asking if a STEMI Network 
in a large metropolitan area in Kentucky would be able to replicate similar results.  It was 
hypothesized that the implementation of a STEMI Network in this metropolitan area would 
decrease D2B times.  Furthermore, it was hypothesized that D2B times would improve 
regardless of type of presentation to the hospital.  These types of presentations included walk-in 
patients, EMS patients, and transfer patients.   Moreover, the question was asked if there was a 
difference between D2B times and whether or not the patient presented during working hours or 
non-working hours.  An ANOVA was conducted to compare the results of pre-implementation 
and post-implementation data.  The results of these are discussed in the following paragraphs. 
Data suggests that the study population in the pre-implementation group compared to the 
post-implementation group significantly differed in the conditions of hypertension (p = 0.0017) 
and diabetes non-insulin requiring (p = 0.0445) (see Table 3).  The remaining co-morbidities and 
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pre-existing conditions did not show any statistical significance and wasn’t vastly different 
demographically or clinically (Tables 1-3). 
Overall Pre and Post D2B Times 
The main findings of this project are that the implementation of a STEMI Network (or an 
organized regional system for treatment of STEMIs) effectively decreased D2B times for all 
patients across all types of presentations.  In the pre STEMI Network implementation cohort, the 
overall mean D2B time was 136.3 minutes, whereas post-implementation the overall mean D2B 
time dropped to 80.5 minutes with a log p-value of 0.005.  This shows that the STEMI network 
implementation was successful in decreasing D2B times for all patients who presented in the pre-
implementation group (N= 32) when compared to the post-implementation group (N = 82).  This 
decrease in D2B time reflects several process improvements for the treatment of STEMI patients.  
Presentation Type and D2B Times  
Independent t-tests revealed D2B times decreased across all types of presentation.  
However, through exploration of this data it was revealed that only the transfer patients had a 
statistically significant p-value.  Despite transfer patients being the only statistically significant 
presentation type, this does not mean that the STEMI Network was only successful for transfer 
patients.  Rather, this simply means transfer patients saw the biggest improvement in D2B times.  
Previous research conducted by Nallamothu, Bradley, and Krumholz (2007) states that for every 
15 minute time period beyond 90 minutes there is an associated increased risk of in-patient death 
from complications.  Therefore, although EMS and walk-in patients did not see a statistically 
significant improvement, any time saved is muscle saved and most likely will contribute to 
improved patient outcomes and less morbidity and mortality.  Through the initial bivariate 
analysis, there were time decreases across all types of presentation.  It should be noted that 
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independent t-tests were initially conducted that revealed a skewed output (Table 5).  Therefore, 
an ANOVA was conducted using the log D2B times. 
The results of the ANOVA conducted to examine patients D2B times dependent upon 
type of presentation revealed that there was a highly significant interaction between 
implementation of a STEMI Network and presentation type.  That is, the results suggest that 
there is a difference between impact of Network implementation and strength of interaction 
based on presentation.  The STEMI Network, according to the results suggested that the 
strongest interaction seemed to be for transfer patients (whose log D2B mean time in minutes 
started at 238.6 and after implementation decreased to a mean time of 88.8 minutes, bivariate log 
p-value = 0.004).  Additionally, the results of this ANOVA also revealed that there was a strong 
relationship between network implementation and decrease in D2B time for walk-in patients 
whose mean time started at 98.0 minutes and decreased to a mean time of 88.7 minutes (log p-
value =.82).  When examining the results for mean time in minutes for patients who arrived via 
EMS, there was not a decrease.  Rather, there was essentially no change in this measure; the 
times (in minutes) remained about the same for EMS patients (pre-implementation mean time 
was 72.3 minutes, post-implementation mean time was 74.5, log p-value = 0.1425). 
 The results of the decrease in D2B time for transfer patients and walk-in patients suggests 
that patients from both types of presentation were reperfused more quickly than were their 
counterparts who presented via EMS when accounting for other variables.  While EMS patients’ 
D2B times did not reveal a statistically significant improvement over the course of the study 
periods, this does not suggest the STEMI Network was not successful for those individuals.  This 
could have been for a variety of reasons.  For example, it may have been that a patient who 
presented via EMS was not perfused in a timely manner due to the instability of their condition. 
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That is, it wouldn’t be extraordinary if a patient presented in cardiogenic shock or respiratory 
distress needed emergent and prioritized stabilization where reperfusion came second to other 
life-saving interventions. 
Additionally, the overall picture that can be seen from Table 7 examines the effect of all 
variables in conjunction with each other.  That is, although EMS patients (irrespective of the 
implementation) do have the lowest overall D2B time (Tables 5 and 7); when looking at the 
interaction of presentation and pre vs. post it revealed that the implementation was most effective 
for the transfer patients (p= .004 log value) (Table 7).  Conversely, the 2 minute increase in log 
D2B for the EMS patients in the ANOVA analysis isn’t a significant increase (72 minutes pre 
and 74 minutes post).  It simply indicates that the implementation was more effective for walk-in 
and transfer presentation types.  When looking at the bivariate association between D2B and pre 
vs. post just for the EMS presentations it is demonstrated that the mean D2B did decrease, just 
not significantly (pre - 85 minutes and post - 76 minutes).  
Working Versus Non-Working Hours D2B Times 
The results of the ANOVA conducted to examine the interaction of time and day of 
presentation on patient D2B times revealed that there were no significant differences between 
patient presentation during working hours (0700-1700) and patient presentation during non-
working hours (1700-0700, weekends, and holidays).  However, p = .09 is approaching 
significance at p < .05 but is not yet significant.  Therefore, this may suggest a need to 
investigate further whether there is a difference between impact of network implementation and 
strength of interaction based day and time of presentation.  That is, patients who presented 
during non-working hours had a pre-implementation D2B time in minutes of 202 while the post-
implementation D2B time mean was 88 minutes.  This suggests that patients who presented after 
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working hours, on weekends, and on holidays experienced the greatest benefits of the STEMI 
Network.  Upon further exploration the actual times illustrate that the STEMI network 
implementation revealed most significance when examining the improvements of the non-
working hours D2Bs. 
Limitations 
 
 This project had several important limitations that could potentially affect the validity of 
reported results.  First, this study holds the characteristics associated with observational 
retrospective cohort studies.  That is, the PI has no control over exposure or outcome assessment 
and there is a reliance on the record keeping of others.  
Second, the use of EMRs as a reliable source for information and data collection is an 
unending focus in the profession of nursing and healthcare in general (Westra, Delaney, 
Konicek, & Keenan, 2008).  The clinical documentation of data for the use of program 
evaluation and research is in an ongoing process of investigation for its reliability and validity.  
Nevertheless, nurses must be able to document and describe clinical practice through the 
documentation of an intervention (Westra et al., 2008).  Moreover, the ability to use 
documentation as a source of information allows researchers to demonstrate the way in which 
nursing interventions can affect patient outcomes (Westra et al., 2008). 
 Third, only the PI was authorized to review the medical records for data collection, which 
consequently precluded the establishment of inter-rater reliability and potentially introduced 
misclassification bias to the findings.  Furthermore, misclassification bias could have occurred at 
the time of the IT medical record selection due to inaccurate billing and diagnosis codes. 
 Fourth, the use of pre and post study design model without any randomization or specific 
control group could make it difficult to determine if the reduction in D2B was due to the various 
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changes that were made in this specific STEMI Network such as: (1) providing immediate 
assessment in the field, which will allow the patient to skip the initial emergency department 
(ED) assessment and allow for immediate transportation directly to the cath lab; (2) elimination 
of the timely process of unloading patients at a local hospitals that are non-PCI capable; and (3) 
the providing of continuous feedback and education on the process and importance of timely 
treatment and care of STEMI patients to staff involved.  Although a concurrent cohort may have 
been able to minimize potential influence of unanticipated events, it would have not been 
logistically feasible to implement.  Finally, the findings may not be generalizable to other 
facilities or populations as the study was conducted at only one receiving center hospital and 
only patients with documented STEMIs were included.  
Implications for Practice 
 
 Despite the limitations listed above, the results of this study are likely to be useful in a 
number of ways.  Since CHD is the major cause of mortality for adults globally as well as 
nationally and because every 15 minute time period beyond 90 minutes there is an associated 
increased risk of in-hospital death from complications (Nallamothu, Bradley, & Krumholz, 
2007), it is critical for the medical team to have the best information possible to help guide them 
as they try to lower D2B times.  This goal can be supported by the body of evidence that 
demonstrates the relationship between decreased morbidity/mortality and door to balloon (D2B) 
and the assertion that there is a continuous relationship between shorter D2B times and better 
survival for patients who undergo primary PCI for a STEMI (Antonuicci et al, 2002; Berger et al, 
1999; Cannon et al, 2000; McNamara et al, 2006; Brodie et al, 2001).   
 The implementation of a STEMI Network for the treatment of acute STEMIs in a large 
metropolitan hospital in Kentucky has led to a significant overall reduction in D2B times.  When 
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patients were identified as having a STEMI, treatment protocols were initiated in a time sensitive 
fashion thereby facilitating these improvements (decreases) in D2B time.  This is of critical 
importance especially when considering recent studies that suggest even small improvements in 
D2B times have a direct relationship to patient mortality (Nallamothu, Bradley, & Krumholz, 
2007; McNamara et al., 2006).  
Implications for Education 
 This study provides an important example of evidence to support the use of a method for 
continuous program evaluation.  In order to carry out a continuous program evaluation, there 
needs to be a framework in which to use as a guide.  A useful quality improvement plan in this 
case may perhaps be best implemented with the use of Six Sigma methodology.  The Six Sigma 
methodology is a quality improvement tool that was first developed and used by the Motorola 
Corporation in the 1970s (Harry, 2000).  This is an evaluation tool that has more recently been 
adapted to use in the medical field in order to attempt to be more efficient and create less error 
(Schweikhart, 2009).  Specifically, Six Sigma can be useful to analyze and modify complicated 
and time sensitive processes that involve multiple disciplines and treatment areas (e.g., EMS, 
ED, cath lab) (Kelly et al., 2010).  Consequently, this tool is particularly useful in exploring any 
issues with the rapid reperfusion of patients who present with a STEMI.  One study that occurred 
at Wake Forest Hospital used the Six Sigma methodology to aid in the improvement of hospital 
D2B times (Kelly et al., 2010).  Thus, the authors reported that after process analysis and 
implementation of improvements, mean D2B times decreased from 128 minutes to 90 minutes.  
This improvement was sustained. Similarly, for this project, it may be useful to use the Six 
Sigma framework to improve specific areas of the STEMI Network processes, specifically in the 
category of EMS STEMI times.  
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Implications for Future inquiry 
 There are several areas for future research when attempting to decrease D2B times for 
patients who present with a STEMI.  That is, are any barriers becoming apparent with current 
STEMI Network protocol?  What are possible ways in which to work through those barriers 
while holding true to the best-practice based on AHA guidelines?  Another area for future 
inquiry might perhaps lie in an effort to integrate disciplines for optimal outcomes for STEMI 
patients.  This will take a continuous evaluation with a multidisciplinary approach to discuss 
processes, goals, concerns with current protocols and make suggestions as to how to make 
improvements.  Additionally, individual stakeholders such as the receiving hospital, the referring 
hospitals, healthcare providers, EMS, and local patient populations need to be involved in future 
research.  In addition to the stakeholders as individuals, further research should be taken into 
consideration with regard to the relationships between and within the stakeholders including but 
not limited to receiving hospital relationship with outlying facilities, receiving hospital 
relationship with local EMS companies, local patient population characteristics, and other 
variables specific to an institution’s location and demographics.  Finally, further research related 
to D2B time should include factors that take into consideration geographic location as there are 
various aspects to any location that may influence D2B times. 
Conclusion 
 
This study aimed to determine if the implementation of a STEMI Network could decrease 
walk-in Door to Balloon (D2B) times, decrease EMS D2B times, decrease the D2B time of 
patients transported from satellite hospitals, and determine if there is an association between the 
time of day (working hours versus non-working hours) when the patient was admitted and D2B 
times.  Results suggest that the implementation of a STEMI Network for the treatment of acute 
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STEMI patients in a large metropolitan area in Kentucky by way of regional network is an 
effective strategy to help reduce D2B times in patients who present with STEMIs.  This is 
critical because as the literature suggests, even small improvements in D2B are important and 
demonstrate a direct relationship between a decreased D2B and decreased mortality rates 
(Nallamothu et al., 2007; McNamara et al., 2006).  The clinical significance of this finding for a 
state that has the sixth highest rate of heart disease mortality in the nation is critical and has the 
potential to decrease mortality and morbidity (Haverson, Ma, & Hamer, 2004; KDPH, 2009a; 
KDPH 2009b; & Rugg, Bailey, & Browning, 2008).  Future research and ongoing education of 
and with the multidisciplinary team can be instrumental to improving the design, 
implementation, and evaluation in order to facilitate the growth of future organized systems of 
STEMI care and STEMI Networks.  
64 
 
References 
ACC/AHA Guidelines 2002. 
Alspach, J.G. (2006). AACN Core Curriculum for Critical Care Nursing (6th ed) Saunders. 
American Diabetes Association: Standards of medical care in diabetes–2006. Diabetes Care 29 
(Suppl. 1):S4 –S42, 2006. 
American Heart Association (2013). Retrieved from 
http://www.heart.org/HEARTORG/HealthcareResearch/MissionLifelineHomePage/Lear
n-About-Mission-Lifeline_UCM_438708_Article.jsp. 
American Heart Association (2013). Retrieved from 
http://www.heart.org/HEARTORG/HealthcareResearch/MissionLifelineHomePage/Lear
nAboutMissionLifeline/STEMI-Systems-of-Care_UCM_439065_SubHomePage.jsp. 
Antman E.M., Hand M., Armstrong P.W., Bates E.R., Green L.A., Halasysmani L.K.,…Yancy 
C.W. (2008). 2007 Focused update of the ACC/AHA 2004 guidelines for the 
management of patients with st-elevation myocardial infarction: a report of the American 
college of cardiology/American heart association task force on practice guidelines: 
developed in collaboration with the Canadian cardiovascular society endorsed by the 
American academy of family physicians: 2007 writing group to review new evidence and 
update the ACC/AHA 2004 guidelines for the management of patients with st-elevation 
myocardial infarction, writing on behalf of the 2004 writing committee. Circulation 117: 
296-329. 
Antman, E.M., Anbe, D.T., Armstrong, P.W., Bates, E.R., Green, L.A., Hand….Jacobs, A.K. 
(2004). ACC/AHA guidelines for the management of patients with st-elevation 
myocardial infarction: executive summary: a report of the American college of 
65 
 
cardiology/American heart association task force on practice guidelines. Circulation. 
110:588-636. 
Antman, E.M., Hand, M., Armstrong, P.W., et al. (2008). 2007 focused update of the ACC/AHA 
2004 guidelines for the management of patients with st-elevation myocardial infarction. 
Journal of American College of Cardiology. 51:210-247. 
Antonuicci, D.,Valenti R., Migliorini A., Moschi G., Trapani M., Buonamici P,… Cerisano G, 
(2002).  Relation of time to treatment and mortality in patients with acute myocardial 
infarction undergoing primary coronary angioplasty. American Journal of Cardiology. 
89(11): 1248-52. 
Berger P.B., Ellis S.G., Holmes D.R. Jr, Granger C.B., Criger D.A., Betriu A.,…Topol E.J., 
(1999). Relationship between delay in performing direct coronary angioplasty and early 
clinical outcome in patients with acute myocardial infarction: results from the global use 
of strategies to open occluded arteries in acute coronary syndromes (GUSTO-IIb) trial. 
Circulation. 100(1): 14-20. 
Brodie B.R., Stone G.W., Morice M.C., Cox D.A., Garcia E., Mattos L.A. (2001). Importance of 
time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial 
infarction (results from the stent primary angioplasty in myocardial infarction trial). 
American Journal of Cardiology. 88:1085-1090. 
Candido R, Srivastava P, Cooper ME, Burrell LM. (2003). Current opinion in investigational 
drugs. Diabetes mellitus: a cardiovascular disease. Sep;4(9):1088-94. 
Cannon C.P., Gibson C.M., Lambrew C.T., Shoultz D.A., Levy D., French W.J…Tiefenbrunn, 
A.J. (2000). Relationship of symptom-onset-to-balloon time and door-to-balloon time 
66 
 
with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 
283:2941-2941. 
Centers for Disease Control and Prevention (CDC). (2015). Retrieved on February 6, 2015. 
http://nccd.cdc.gov/DHDSP_DTM/# 
Chen Y., Wang C., Yang X., Wang L., Sun Z., Liu H., Chen L. (2012).  Independent no-reflow 
predictors in female patients with st-elevation myocardial infarction treated with primary 
percutaneous coronary intervention. Heart Vessels. 27: 243-249. 
Close to the Heart of Kentucky—A Report on the Status of Cardiovascular Disease in the 
Commonwealth: Chronic Disease Prevention and Control Branch Division of Adult and 
Child Health Improvement, Kentucky Department for Public Health; 2004. 
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 
(2001). Executive summary of the third report of the national cholesterol education 
program (NCEP) expert panel on detection, evaluation, and treatment of high blood 
cholesterol in adults (Adult Treatment Panel III). JAMA 285: 2486–2497. 
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and 
stroke statistics—2014 update: a report from the American Heart Association. 
Circulation. 2014 ;128. 
Halverson, J., Ma, L., & Harner, E.  (2004). An analysis of disparities in health status and access 
to care in the Appalachian region. Appalachian Regional Commission. Washington, DC. 
Harry, M.S.R. (2000). Six Sigma. New York, NY. Doubleday Publishers. 
Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular 
disease in the United States: a policy statement from the American Heart Association. 
Circulation. 2011;123:933-44. Epub 2011 Jan 24. 
67 
 
http://my.clevelandclinic.org/services/heart/disorders/cad/hic_Heart_Attack/mi_types 
Jacobs A.K., Antman, E.M., Ellrodt, G., Faxon, D.P., Gregory, T., Mensah….Smith, S.C. (2006). 
Recommendation to develop strategies to increase the number of st-segment-elevation 
myocardial infarction patients with timely access to primary percutaneous coronary 
intervention. Circulation. 113: 2152-2163. 
KDPH 2009a. Kentucky Department of Public Health, County health profiles. Retrieved (2014, 
Oct 3) from http://chfs.Kentucky.gov/dph/epi/cohealthprofiles.htm. 
KDPH 2009b. Kentucky Department of Public Health, Office of Vital Statistics. 
Kelly, E., Kelly, J., Hiestand, B., Wells-Kiser, K., Starling, S., & Hoekstra, J. (2010). Six sigma 
process utilization in reducing door-to-balloon time at a single academic tertiary care 
center. Progress in Cardiovascular Diseases, 53(3), 219-226. 
Learn the Heart. (2013). Retrieved from http://www.learntheheart.com/CAD-STEMI-
SpecialSituations.html. 
McNamara R.L., Wang Y., Herrin J., Curtis J.P., Bradley E.H., Magid D.J…NRMI 
Investigators. (2006). Effect of door-to-balloon time on mortality in patients with st-
segment elevation myocardial infarction. Journal of American College of Cardiology. 
47:2180-2186. 
Murphy SL, Xu JQ, Kochanek KD. Deaths: Final data for 2010. Natl Vital Stat Rep. 2013;61(4). 
http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_04.pdf 
Nallamothu, B.K., Bates, E.R., Wang, Y., Bradley E.H., Krumholz, H.M. (2006). Driving times 
and distances to hospitals with percutaneous coronary intervention in the United States: 
implications for prehospital triage of patients with st-elevation myocardial infarction. 
Circulation. 113:1189-1195. 
68 
 
Nallamothu, B.K., Bradley, E.H., & Krumholz, H.M. (2007). Time to treatment in primary 
percutaneous coronary intervention. New England Journal of Medicine; 357:1631-1638. 
Racial/Ethnic and Socioeconomic Disparities in Multiple Risk Factors for Heart Disease and 
Stroke—United States, (2003). MMWR Morb Mortal Wkly Rep. Feb 11 2005;54(5):113-
117. 
Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics—2007 update: a 
report from the American Heart Association statistics committee and stroke statistics 
subcommittee. Circulation. 115(5):e69-171. 
Rugg, S.S., Bailey, A.L., & Browning, S.R. (2008). Preventing cardiovascular disease in 
Kentucky: epidemiology, trends, and strategies for the future. Kentucky Medical 
Association Journal CME. 153-167 April 2008. Vol 106. 
Silber S., Albertsson P., Aviles F.F., Camici P.G., Columbo A., Hamm C., Jorgensen E.,…Wijns 
W. (2005). Task force for percutaneous coronary interventions of the European society of 
cardiology guidelines for percutaneous coronary interventions. The task force for 
percutaneous coronary interventions of the European society of cardiology. European 
Heart Journal. 26:804-810. 
Schweikhart, S.D. (2009). The applicability of lean and six sigma techniques to clinical and 
translational research. Journal of Investigative Medicine, 57: 748-755. 
World Health Organization. (2015) Retrieved January 7, 2015 from 
http://www.who.int/mediacentre/factsheets/fs317/ 
 
69 
 
Table 1: Descriptive Statistics for Demographic Characteristics. 
Variable  N Pre-  
Mean 
Post-
Mean 
Overall 
Mean 
Standard 
Deviation 
Maximum 
Value 
Minimum 
Value 
Age (in years)  156 60.0 58.8 59.3 13.7 102 26 
Gender         
 Male 109 66.0% 71.7% 69.9% -- -- -- 
 
 Female 47 34.0% 28.3% 30.1% -- -- -- 
Race          
 Caucasian 125 74.0% 83.0% 80.1% -- -- -- 
 
 African 
Am. 
28 22.0% 16.0% 17.9% -- -- -- 
 
 Hispanic 3 4.0% 0.9% 1.9%     --     --     -- 
BMI %   28.4% 29.3% 29.0% 7.52 68.3 13.5 
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Table 2: Descriptive Statistics for Laboratory Results. 
Variable N Pre-  
Mean 
Post-
Mean 
Overall 
Mean 
Standard 
Deviation 
Maximum 
Value 
Minimum 
Value 
HgA1C 70 7.18 6.55 6.69 2.0 14.3 3.90 
 
HDL 116 45.1 39.2 41.19 12.7 99.0 22.0 
 
LDL 115    128 106 113.5 39.18 225 23 
 
Total 
Cholesterol 
109    184 174 177 50.69 440 60 
 
  
71 
 
Table 3: Descriptive Statistics for Co-morbid and Pre-existing Conditions (N = 156). 
 Co-Morbidities   Pre- Mean Post-Mean Overall Mean Chi-square 
Hypertension  48.0% 73.6% 65.4% 0.0017 
Smoking  52.0% 53.8% 53.2% 0.8359 
Hyperlipidemia  44.0% 53.8% 50.6% 0.2545 
Statin Therapy  20.0% 30.2% 26.9% 0.1806 
Diabetes Non-Insulin Requiring 10.0% 23.6% 19.2% 0.0445 
Prior MI  16.0% 17.9% 17.3% 0.7668 
Prior PCI  12.0% 18.9% 16.7% 0.2828 
Prior CABG  6.0% 10.4% 8.97% 0.3720 
Non-statin lipid 
lowering Therapy 
 2.0% 7.6% 5.8% 
 
0.1655 
Diabetes Insulin Requiring 4.0% 4.7% 4.49% 0.8400 
 Diet Controlled 2.0% 0% 0.6% 0.1441 
 No Treatment 2.0% 3.77% 3.2% 0.5573 
Cardiogenic Shock  6.0% 1.9% 3.2% 0.1735 
Cocaine   0% 0% 0% -- 
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Table 4: Type of Presentation, % of patients. 
Presentation Pre-  
 
Post- Overall  
Walk-in 8.0% 8.5% 8.3% 
EMS 36.0% 31.1% 32.7% 
Transfer 56.0% 60.4% 58.9% 
Total 32.1% 67.9% 100.0% 
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Table 5: D2B Times (in minutes). 
Presentation  Mean D2B 
Time 
Standard 
Deviation 
Maximum 
Value 
Minimum 
Value 
Log of the D2B 
p value 
Overall Pre-implementation 136.3    0.005 
 Post-implementation 80.5     
Walk-in       
 Pre-implementation 98 51 134 62 0.8212 
 Post-implementation 86 33 120 54  
EMS        
 Pre-implementation 85 21 140 61 0.1425 
 Post-implementation 76 22 164 46  
Transfer       
 Pre-implementation 155 134 628 86 0.0047 
 Post-implementation 92 58 474 55  
 
 
 
 
74 
 
Figure 1: Type of Presentation and D2B times. 
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Table 6: Working hour vs. Non-working hour D2B times (in minutes). 
Variable  D2B 
Time 
Standard 
Deviation 
Maximum 
Value 
Minimum 
Value 
Log p value 
Working Hours  
(m-f, 0700-1700) 
      
 Pre-implementation 101 36.9 183 61 0.0079 
 Post-implementation 74 14.1 102 46  
Non-Working Hours 
(1700-0700, 
weekends, holidays) 
      
 Pre-implementation 137 133.7 628 69 0.05 
 Post-implementation 91 55.1 474 54  
 
 
76 
 
Table 7: ANOVA Analysis.  
 
Variable Implementation 
Period 
Log D2B time in 
minutes 
Standard 
Error 
DF F value P value          
p < .05 
Overall       
 pre 136.3 32.5 107 5.83         0.017 
 post 80.5 26.9 107   
Walk-in       
 Pre 98.0 87.0 107 6.17 .0029 
 Post 78.3 72.6 107   
EMS       
 Pre 72.3 32.1 107   
 Post 74.5 22.5 107   
Transfer       
 Pre 238.6 30.9 107   
 Post 88.8 18.9 107   
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Table 7 (continued) 
Variable Implementation 
Period 
Log D2B time in 
minutes 
Standard 
Error 
DF F value P value          
p < .05 
Working Hours       
 Pre 70.1 39.4 107 2.94 .0896 
 Post 72.2 34.6 107   
Non-working 
hours 
      
 Pre 202.5 38.8 107   
 Post 88.9 26.3 107   
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Abstract 
The purpose of this manuscript is twofold: (1) highlight the disparity between socioeconomic 
status (SES) and cardiovascular disease (CVD) and (2) suggest focus areas to attempt to decrease 
the disparities between SES and CVD.  Although it is well known that CVDs are diseases related 
the physical and chemical environment (e.g. high blood pressure, diabetes, cholesterol, tobacco 
use, sedentary lifestyle), it is less well known how social and economic status (e.g. income, 
education, socioeconomic status, occupation) influence CVD.  Social determinants of health do 
not simply come down to social inequalities; however, social inequalities help to demonstrate the 
shortcomings our healthcare system in the setting of  SES.  This literature review presents 
several studies that highlight the correlation between SES and CVD (O’Connor & Wellenius, 
2012; & Pollack et al, 2012).  Finally, by using Healthy People 2020 as a guide, this manuscript 
will also illuminate several areas to focus on (e.g., medical care, public education, public policy, 
and research) in an attempt to decrease the disparities between socioeconomic status (SES) and 
CVD. 
 Keywords: Socioeconomic status (SES), cardiovascular disease (CVD), social 
determinants 
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Introduction 
There is an abundance of literature and it is widely known that there exists a relationship 
between cardiovascular disease (CVD) and risk factors such as high blood pressure, cholesterol, 
smoking, diabetes, and sedentary lifestyle.  Conversely, there is much less known about the 
social determinants of an individual’s CVD.  Social determinants in the setting of health and 
health care can be understood as the social conditions in which an individual lives, an 
individuals’ working conditions, and/or their social relationships (Lang, Lepage, Scheiber, 
Lamy, & Kelly-Irving, 2012).  These conditions are influenced and shaped by a variety of factors 
including an individual’s education, income, occupation, employment status, and living 
conditions (Morgenstern, 1985).  Disparities in health outcomes related to socioeconomic status 
(SES) have long been recognized as a continuing and perhaps an even increasing public health 
problem (Lantz et al, 1998).  
The National Institute of Health (2014) defines health disparities as the differences in the 
incidence, prevalence, mortality, and burden of diseases as well as other adverse health 
conditions that exist among specific population groups in the United States.  According to 
Healthy People 2020 (Healthy People, 2015), some of the leading disparities in the United States 
are cardiovascular disease (CVD), diabetes, cancer, HIV/AIDS, infant mortality, asthma, and 
mental health.  This review focuses on the disparities in cardiovascular disease (CVD) in the 
setting of socioeconomic status (SES). 
CVDs are a group of disorders of the heart and blood vessels.  According to the World 
Health Organization (2014),  the diseases that make up CVD are; coronary heart disease (CHD), 
which is a disease of the blood vessels that supply blood to the heart; cerebrovascular disease 
(stroke), which is a disease of the blood vessels that supply blood to the brain; peripheral arterial 
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disease, which is a disease of the blood vessels that supply blood to the arms and legs, rheumatic 
heart disease, which is damage to the heart muscle and heart valves from rheumatic fever; 
congenital heart disease; and deep vein thrombosis and pulmonary embolism.  The most 
common of these are CHD and stroke which, both of which are the most widespread and are the 
most costly in the U.S.  Specifically, it is reported that heart disease and stroke cost the U.S. over 
$500 billion in health care expenditures and associated expenses in the year 2010 (Lloyd-Jones, 
Adams, & Brown, et al., 2010).  Collectively, these diseases make up the umbrella term 
cardiovascular disease (CVD). 
Healthy People 2020 reports the following objectives in regard to cardiovascular disease: 
(1) increase overall cardiovascular health in the U.S. population, (2) reduce CHD deaths, (3) 
increase the proportion of adults who have their blood pressure measured and how many of these 
individuals can report whether their blood pressures are high/low/normal, (4) reduce the 
proportion of individuals with hypertension, (5) reduce the number of individuals who have high 
cholesterol, and (6) increase the proportion of adults who are aware of the early warning 
symptoms and signs of a heart attack, etc. (Healthy People, 2015).  Unfortunately, according to 
the 2004 Behavioral Risk Factor Surveillance System (BRFSS), the Commonwealth of Kentucky 
had not met any of the stated objectives for CVD from Healthy People 2010.  If there is to be any 
advancement towards meeting some of Healthy People 2020’s goals, interventions and public 
health initiatives need to be more effective at addressing the prevention and treatment of CVD 
(Rugg, Bailey, & Browning, 2008).  
 The purpose of this review is twofold: (1) highlight the disparity between socioeconomic 
status (SES) and cardiovascular disease (CVD) and (2) suggest focus areas to attempt to decrease 
the disparities between SES and CVD.  CVDs are diseases related not only to the physical and 
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chemical environment but also to the social and economic one.  While the question of social 
determinants of health does not only mean social inequalities in health, social inequalities do 
help to reveal the shortcomings of our healthcare system in the setting of SES. 
Quantifying Cardiovascular Disease Globally and Nationally 
On the global level, CVD is the number one cause of death with more people dying from 
CVD than any other cause (Rosamond, Flegal, & Friday et al., 2007).  The WHO (2014) 
estimated that 17.5 million people died from CVDs in 2012 which represents 30% of all global 
deaths.  Of these deaths, an estimated 7.4 million were due to CHD which is a disease that 
affects the blood vessels of the heart and is one of the many diseases that make up the 
overarching disease of CVD.  It is important to note that low- and middle-income countries are 
disproportionally affected: specifically, over 80 percent of CVD deaths take place in low- and 
middle-income countries and occur almost equally in men and women (WHO, 2011b; CDC, 
2015). 
In the United States, CVDs are the primary cause of death and are major causes of 
disability (Centers for Disease Control and Prevention (CDC), 2006).  The CDC estimates that 
720,000 heart attacks occur every year and according to the American Heart Association (CDC, 
2015), 80 million people in the U.S had one or more forms of the previously mentioned CVDs in 
2006.   Nearly one in every four deaths can be attributed to CVD (Murphy, Xu, & Kochanek, 
2013).  Moreover, the estimated direct and indirect cost of CHD in the U.S. in 2011 was 320.1 
billion dollars (CDC, 2015; AHA, 2015).  
Quantifying Cardiovascular Disease in Kentucky 
Coronary heart disease (CHD) or heart disease is a group of diseases that can cause heart 
attacks and is the leading cause of death in Kentucky and the nation.  It is the most common form 
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of CVD and in 2005 accounted for 76 percent of all CVD deaths in the Commonwealth of 
Kentucky.  This translated to over 10,000 deaths. As of 2006, Kentucky had the sixth highest rate 
of heart disease mortality in the nation, while Mississippi, District of Columbia, Alabama, 
Oklahoma, and West Virginia, had the top five positions, respectively  (Haverson, Ma, & Hamer, 
2004; KDPH, 2009a; KBDP 2009b; & Rugg, Bailey, & Browning, 2008).   
In addition to the CVD and CHD rates, Kentucky also leads the nation in the prevalence 
of several of the known risk factors for CVD (CDC, 2011).  While the rates for CVD in 
Kentucky remain high, the prevalence of the risk factors for CVD sets the population up for 
disease sequalae. According to Kentucky’s Behavioral Risk Factor Survey (BRFSS) (2012), 
approximately 6.6 percent of adults in Kentucky have been told by a health care professional that 
they have had a heart attack compared to the national percentage of 4.5 percent.  Similarly, 6.1 
percent have been told they have CHD while the national percentage is 4.3 percent.  Kentuckians 
who have been told they have had a stroke is 4.2 percent while the national percentage is 2.9 
percent, and those who have been told they have diabetes is about 10.7 percent while the national 
percentage is 9.7, and in the 2012 report, those who were classified as obese were 31.3 percent 
and comparatively that same year, the national percentage for obesity based on body mass index 
was 21.7 percent.  Finally, those who are considered current smokers (as defined by currently 
smoking cigarettes every day or some days) in Kentucky are 28.3 percent while the national 
average for the same classification is 19.6 percent (Figure 1).   
Because Kentucky leads the nation in the prevalence of the known risk factors for CVD, 
it would stand to reason than that Kentucky also leads the nation in a more comprehensive 
umbrella diagnosis of CVD (KDPH, 2009b).  The 2012 annual report from the BRFSS, 
illustrates the disparity between the national rates of CVD (specifically CHD) and the 
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Commonwealth of Kentucky’s rate of CHD.  That is, in the areas of obesity, diabetes, CHD, 
stroke, heart attack (which are all sub-categories of CVD) Kentucky has a higher prevalence of 
each of those diseases than does the rest of the nation. 
In addition to the above statistics, the KDPH (2009b), also reports that men in Kentucky 
have higher heart disease death rates than women.  Moreover, the rates for both men and women 
in Kentucky are higher than the rates for men and women nationwide.  Similar disparities are 
also seen among whites and blacks (KDPH, 2009b).  In both Kentucky and the U.S., heart 
disease death rates for blacks are higher than they are for whites.  The age-adjusted heart disease 
mortality rate for white Kentuckians (250 per 100,000) is higher than it is for white Americans 
(212 per 100,000).  The rate for black Kentuckians (292 per 100,000) is higher than it is for 
black Americans (277 per 100,000) (KDPH, 2009b). 
Quantifying Socioeconomic Status 
 There are many different ways in which to conceptualize and thus measure SES.  Some 
of those variables that can be used to measure SES are education, income, social class, 
occupation, employment status, living conditions, status, power, etc. (Morgenstern, 1985).  In 
this review the following three variables will briefly be discussed; income, occupation, and 
education in the setting of access to health and health care.  Income is a typically very good 
marker of SES (Libertos, Link, & Kelsey, 1988; & Morgenstern, 1985).  Information concerning 
income can provide access to goods and services that include but are not limited to quality 
education and quality health care.  However, this is a difficult variable to measure.  That is, 
individual or family income may be measured or incomes can be adjusted to a specific family 
size.  Additionally, this can be a difficult number to gain access to due to the sensitivity of it and 
need for assurance of confidentiality.  Second, occupation is an important status characteristic in 
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modern societies and is often used as a measure of SES.  Finally, according to Libertos et al. 
(1985), education is often used as a measure of SES.  This may be for a variety of reasons 
including the possibility of the ease in which subjects feel when answering education questions 
compared to income questions. 
People in low- and middle-income areas, specifically those in Kentucky, may be more 
exposed to risk factors such as lack of regular physical activity, exposure to first and secondhand 
smoking, access to poor or inadequate dietary programs, and cardiovascular associated health 
problems such as hypertension and diabetes (BRFSS, 2012), leading to CHD and other CVDs.  
Simultaneously these individuals many times do not have the benefit of prevention programs 
compared to people in higher-income areas.  Individuals who live in low income areas of 
Kentucky who suffer from CVDs have less access to effective and equitable health care services 
which respond to their needs (including early detection services) (Rugg et al., 2008).  This may 
result in individuals from low- and middle-income areas dying younger than their peers within a 
higher-income category from CVDs.  Moreover, the poorest people in low- and middle-income 
areas are affected most significantly (BRFSS, 2012).  Additionally, on a larger level, CVDs place 
a heavy burden on the economies of low- and middle-income counties (WHO, 2014).  The 
following studies will present the possible correlation between SES and CVD. 
Review of the Literature 
O’Connor and Wellenius (2012) conducted a cross-sectional study of more than 214,000 
respondents using data reported to the CDC 2008 Behavioral Risk Factor Surveillance System.  
The BRFSS survey defined a MSA-metropolitan statistical area as 50,000 or more inhabitants as 
urban and anything less than that was rural.  Additionally, respondents were asked to respond to 
an income question that categorized their incomes from $10,000-$15,000, $15,000-$20,000, 
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$20,000-$25,000, $25,000-$35,000, $35,000-$50,000, $50,000-$75,000, and greater than 
$75,000.  They were asked to answer gender and weight, height, ethnicity, age, and if their 
physician had told them they had angina or CHD.  If they didn’t know they were omitted from 
the study. 
The authors found that areas defined by the BRFSS survey as being a “rural” had 
inhabitants that were more likely to be diagnosed with CHD.  Additionally, after controlling for 
risk factors of income, age, gender, ethnicity, BMI, and tobacco use, it was found that persons in 
a rural environment are still more likely to be diagnosed with CHD than persons in urban 
locations.  
O’Connor and Wellenius (2012) suggested this may be due to actual treatment cost or 
increased rate of complication and mortality among persons of lower SES.  The higher 
prevalence of CHD in rural locations also exacerbates other health care disparities that impact 
the diagnosis and treatment of CHD itself such as, increased difficulty obtaining health 
insurance, longer distances to reach health care facilities, shortage of primary care provider 
(PCP) in rural areas (O’Connor & Wellenius, 2012; Coburn et al, 2009).  Like a vicious circle, 
there is a shortage of PCPs in rural areas; residents of rural states in the US have access to about 
half as many PCPs compared with residents of urban locations, which in turn leads to reduced 
access to care. 
In another cross-sectional study also conducted in 2012, Pollack, Slaughter, Griffin, 
Dubowitz, and Bird examined the association between CHD risk scores and neighborhood SES 
(NSES).  The authors defined NSES using six Census variables which were then summarized 
and organized into indices such as median household income, percent of households below the 
poverty threshold, percent of adults older than 25 with a high school diploma., etc. The 10 year 
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risk of CHD was then calculated using the 2001 Framingham Risk Score (FRS).  The FRS is a 
scale used to estimate an individual’s 10 year risk of CHD.  Fiscella, Tancredi, and Franks 
(2009) found that when adding SES to the calculation, the accuracy of the FRS predicting CHD 
outcomes among low income populations improves.  Pollack et al. (2012) found that an 
individual living in a neighborhood at the 75
th
 percentile of NSES (high NSES) has on average a 
10 year CHD risk that is .16 percentage points lower than a similar person from a neighborhood 
from the 25
th
 percentile.  That is, NSES is significantly associated with CHD risk.  Interestingly, 
NSES has also been found to be linked with smoking, physical inactivity, dietary patterns, and 
obesity both in local and national samples (Pickett & Pearl, 2001). 
All of these studies suggest that individuals living in disadvantaged (or low-income) 
neighborhoods (e.g., neighborhoods near the 25
th
 percentile of NSES) are significantly more 
likely to suffer CHD than those living in advantaged (or higher-income) neighborhoods (e.g., 
neighborhoods near the 75
th
 NSES) (Diez-Roux, et al 1995 & Diez-Roux et al, 2001).  
How to Eliminate the Disparities 
Eliminating the disparities between CVD and SES is critical to reaching the Healthy 
People 2020 goals previously discussed.  There are a variety of different methods in which to 
disseminate knowledge, services, and access to impoverished individuals with lack of health 
insurance.  For example, placing a greater emphasis on recruiting primary care providers to rural 
areas and loan forgiveness for practicing in rural areas may be quick fix solutions but also may 
help to fill a necessary gap.  Other than the aforementioned “quick fixes” how can there be cost 
effective and worthwhile ways to reduce the higher prevalence of CHD in rural settings?  The 
following will focus on four areas that may help to decrease the disparities between SES and 
CVD including: (1) medical care, (2) public education, (3) public policy, and (4) research. 
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Focus on Medical Care  
There are a great deal of variations dependent upon SES in regard to access to care and 
quality of care for CVD, this needs further documentation and measurement so that 
improvements can be made to SES groups that are not receiving adequate care.  Preventative 
services need to be aggressively aimed at lower SES groups and within areas in an effort to 
reduce disparities in CVD risk factors between different SES groups.  There may begin to be a 
slight shift in access to health care with the initiation of the Affordable Care Act (ACA) which 
will bring health insurance to more than 30 million people.  The ACA will attempt to reduce 
disparities with investments in prevention and wellness (DHHS, 2014).  Moreover, there are two 
important initiatives that belong to the ACA: (1) the National Strategy for Quality Improvement 
in Health Care, which includes priorities that will attempt to improve the delivery of health care, 
and (2) the National Prevention and Health Promotion Strategy, which will attempt to bring 
prevention as well as wellness to the frontlines of national policies (DHHS, 2014).  Education 
should be developed to help PCPs and other health care practitioners understand the extent of the 
problem of the correlation between SES and subsequent CVD risk and the factors that lie 
beneath it. 
Focus on Public Education 
Successful interventions to reduce the increase CVD risk factors associated with lower 
SES need to be broad based.  They need to be specific to CVD risk factors as well as the 
conditions of a society that lead to the adoption and maintenance of high-risk behaviors (i.e., 
smoking, drug use, obesity, etc.).  For example, The DHHS (2014) has initiated a plan entitled 
the Strategic Action Plan to End the Tobacco Epidemic.  This is a plan that was released in 2010 
and is built around 4 pillars: (1) engaging the public, (2) supporting evidence based control 
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policies at both at the state and local levels, (3) expecting the HHS to lead by example, and (4) 
advancing research especially in the setting of the government’s regulation of tobacco (DHHS, 
2014).  There needs to be assurance that the targeted audience is involved in developing and 
implementing the education program.  Additionally, there should be exploration of new and 
appropriate techniques and methods to deliver more effective messages to specific and high risk 
populations and to target these high risk populations earlier in a given disease process. 
Focus on Public Policy  
Interestingly, promotion of products associated with increased risk of CVD (e.g., tobacco 
and high fat foods) seems to be targeted toward lower SES.  There should be some consideration 
when creating policies that emphasize the focus of high risk behavior that targets lower SES 
groups. According to Rugg, Bailey, and Browning (2008), there are three general areas that 
warrant continued emphasis.  One is in the area of research.  Public policy programs are 
necessary in order to ensure that federally funded research programs include investigations 
between SES and CVD.  Second, is the area of healthcare.  The AHA and local governmental 
participation in the development of guidelines for appropriate patient care.  Last, should be 
consideration in the area of disease prevention and health promotion.  Continued emphasis on 
federal, state, and local policy initiatives that encourage the development, expansion, and 
implementation of public policy will aid in the prevention of CVD.  For example, Senate Bill 
172 was passed by the Kentucky General Assembly in 2005 which established requirements for 
nutrition regulation in regard to the type of food sold in public schools (Rugg et al., 2008).  
Additionally, programs should be created to help educate all individuals about the prevention and 
control of CVD.  This is crucial when examining the formation of policy initiatives related to the 
control of tobacco and other health initiatives.  
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Focus on Research  
When exploring the relationship between CVD and SES there needs to be a focus on 
trying to understand the behavioral, social, biological, and physiological variables that link CVD 
to SES.  There is a great deal of need to understand the links between economic policy, health 
care coverage, education level, unemployment and their relation to the prevention, incidence, and 
treatment of CVD.  For example, research needs to be designed to improve risk-factor detection 
and management in primary care settings that is based on a better and more holistic 
understanding of the behavior of the patient.  Research needs to be conducted in order to acquire 
knowledge in regard to the intensity of intervention required in order to activate specific 
behavior modifications.  Additionally, there needs to be better measures of outcomes to monitor 
these behavior modifications and the means to maintain these behavior changes (Cooper et al., 
2000).  
In addition to the research gaps mentioned above, research also needs to be conducted in 
healthcare organizations in order to gain a better understanding the role of incentives may play in 
preventative and primary care delivery.  There should be continued research in the managed care 
approach and the potential of multidisciplinary teams (Cooper et al., 2000) as well as the 
possible advantages and disadvantages of care delivered in this fashion.  Finally, there is a need 
to seek a better more comprehensive understanding of the physician and patient factors that may 
affect the adherence to prescribed prevention guidelines that are based within the evidence and 
are cost-effective, but specific to the setting of SES (Cooper et al., 2000). 
Conclusion 
There is a clear message throughout the literature that emphasizes the importance of 
exploring at greater depth the relationship between SES and CVD (O’Connor & Wellenius, 
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2012; Coburn et al, 2009; Pollack et al, 2012; Fiscella et al, 2009; Pickett & Pearl, 2001).  
Evidence suggests that there have been recent decreases in CVD mortality, however, these 
diseases are still the leading cause of death in the United States and Healthy People 2020 reports 
that 129.2 out of 100,000 deaths are due to cardiovascular disease and stroke (Healthy People, 
2015).  While it may seem like most of the significant risk factors for CVD have been identified, 
there are still questions as to other modifiable risk factors that have the ability to influence CVD.  
The main measures of SES have been education, occupation, and income.  However, there are 
other indices of SES that include employment status, indexes of social class, measures of living 
conditions, area-based measures, etc.  Incorporating these additional measures into a 
multidimensional model to assess SES as a whole in the setting of CVD may be a useful piece of 
the puzzle when aiming to reach the goals set by Healthy People 2020 and in improving the 
overall health of the United States. 
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Figure 1: State and National CVD Co-morbidity and Risk Factor Rates 
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Conclusion to DNP Practice Inquiry Project 
 
Julianne Evers, BSN, MS, RN, CCRN 
 
University of Kentucky 
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Acute myocardial infarction (STEMI) is still the leading cause of death in the United 
States and worldwide (CDC, 2014).  Improving outcomes for patients who present with a STEMI 
in the United States is an important public health goal.  Manuscript one presented studies that are 
a part of a small but growing body of literature, they all demonstrate the potential of a 
streamlined and coordinated process in treating STEMI patients.  The optimization of care of 
STEMI patients through the establishment of systems of care could be of great value.  If these 
systems can be implemented correctly (e.g., accounting for differences in regional needs), such 
coordinated care systems have the potential to significantly improve outcomes for these patients.  
All of the studies presented in this integrative review of the literature demonstrate the 
effectiveness of a quality improvement strategies that are directed towards the processes of care 
of STEMI patients from a variety of different regions (i.e., rural, urban, etc.).  
Manuscript three highlighted a clear message throughout the literature of the importance 
of exploring at greater depth the relationship between SES and CVD (O’Connor & Wellenius, 
2012; Coburn et al, 2009; Pollack et al, 2012; Fiscella et al, 2009; Pickett & Pearl, 2001).  
Evidence suggests that there have been recent decreases in CVD mortality, however, these 
diseases are still the leading cause of death in the United States, specifically, Healthy People 
2020 reports that 129.2 out of 100,000 deaths are due to cardiovascular disease and stroke 
(Healthy People 2020, 2015).  Additionally, according to the BRFSS (2012), approximately 6.6 
percent of adults in Kentucky have been told by a health care professional that they have had a 
heart attack, compared to the national percentage of 4.5 percent.  Furthermore, Kentucky has 
19.1 percent of its population living in poverty, compared to 15.9 percent overall in the U.S. 
(KDPH, 2013).   
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Manuscript two was an evaluation of the implementation of a STEMI Network and its 
impact on walk-in D2B times, EMS D2B times, the D2B time of patients transported from 
satellite hospitals, during working hours and non-working hours.  The findings of this practice 
inquiry project support the implementation of a STEMI Network for the treatment of acute 
STEMI patients in a large metropolitan area in Kentucky by way of regional network.  
Specifically, the findings of this practice inquiry project suggest that the STEMI Network has led 
to a significant overall reduction in D2B times.  It is clear that even relatively small 
improvements in D2B have become of crucial importance with current evidence demonstrating a 
direct relationship between D2B and mortality (Nallamothu et al., 2007; McNamara et al., 2006).  
Ultimately, a well-designed and coordinated system of care, created using the existing evidence, 
will improve care for patients with a STEMI. 
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Appendix A 
Waiver of Authorization 
COMPLETE WAIVER OF AUTHORIZATION 
IRB#: Study Title 
14.0687 An Evaluation of the Implementation and Efficacy of a STEMI Network in the Southeastern 
United States 
PRINCIPAL INVESTIGATOR/PROJECT DIRECTOR (PI/PD) 
Name (Last Name, First Name, MI) 
Evers, Julianne M. 
Email Address 
 
Mailing Address – Include University Department (if 
applicable) 
 
 
Telephone Number 
 
Pager/Cell Phone Number 
 
Fax Number 
NA 
 
Please indicate the Covered Entities from which you will seek PHI in this research.  Please check () all that apply. 
 
Affiliated Sites Non-Affiliated Sites 
 
University of Louisville Research Foundation (ULRF) Clinical Sites.  Please check () all that apply. 
 
 
 
 
 
 
 
 
 
[] University of Louisville (Do not remove this  
check.) 
[ ] Louisville Metro Department of Public Health 
& Wellness 
[] Jewish Hospital & St. Mary’s Healthcare [ ] KY Cabinet for Health & Family Services 
[ ] Norton Healthcare, Inc., including Kosair  
Children’s Hospital 
[ ] Seven Counties Services 
[ ] University of Louisville Hospital/J. Graham  
Brown Cancer Center 
[ ] Other(s): 
[ ] Children & Youth Clinic [ ] UL Pathology Flow Cytometry Lab (BCC) 
[ ] Dentistry Clinics (Undergraduate DMD; 
Graduate, Perio, Endo and Ortho; Oral 
Surgery and GPR at ACB; Faculty Practice, 
Graduate Pedodontic Clinic) 
[ ] UL Pathology Special Procedures Lab 
[ ] Family Medicine – (Newburg and Central  
Station; also Geriatrics and Sports Medicine 
at  
Central Station) 
[ ] University Health Services (HSC and Belknap) 
[ ] Harambee Nursing Center [ ] Weisskopf Child Evaluation Center 
[ ] Kidney Disease Program (Dialysis Unit and 
UL  
Renal Transport Lab) 
[ ] WHAS Crusade For Children Audiology & Speech  
Pathology Center 
[ ] Neonatal Follow Up Program [ ] WINGS Clinic – (ACB) 
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This form is to be used when it is not feasible to obtain an authorization prior to viewing PHI (PHI means 
health information plus one or more of the 18 identifiers under the HIPAA regulations). 
 
1.  Please explain why your research project cannot be done using de-identified information. If 
you need to look at identified information, but only will be collecting de-identified 
information, this is still using identified information for your research project. (NOTE: 
Responses “b” and “c” cannot both be checked.) 
 
[ ] a. This project requires health information from multiple holders that needs to be linked 
using identifiers. 
[ ] b. This project requires the retention of identified health information to answer the 
research question. 
[ ] c. While this project does not require the retention of identifiable information, identifiable 
information must be accessed to extract the de-identified information. 
[ ] d. Other - please explain: 
 
2. a. For your research activities, please specify the health information that will be viewed, 
collected, or disclosed by you and the research team to conduct this research.  (Some examples 
of health information may include:  consultation reports, operative records, medical progress 
notes, or diagnostic test results.)  
  Viewed:  Patient’s Medical Record, including: Face Sheet, Attestation sheet, ICIP Charting, 
Nurses Notes;  Labs/diagnostics, Invasive Cardiology, Echocardiography reports, Other 
cardiology reports, Radiology Reports, History and Physicals, Care Managers Discharge 
Disposition Record, Nurse’s Discharge Instructions/Summary, MD’s Progress Notes, MD’s 
Discharge Summary, Medical Records Look-up. 
 
  Collected: Demographic and data collection variables for this study will be collected from the 
various databases of the EMR (i.e., Sovera, ICIP, Clinician Valet, Cerner): age, gender, race, 
height, weight, zip code of patient presenting via EMS, name of Satellite facility of origin or 
referring hospital of origin (within a 35 mile radius of Jewish Hospital). Independent variables 
of interest will be collected from the various databases of the EMR (i.e., Sovera, ICIP, 
Clinician Valet): principal diagnoses and comorbidities (i.e., history of hypertension, 
dyslipidemia, diabetes mellitus (diet controlled, insulin requiring, non-insulin requiring, or no 
treatment), prior myocardial infarction, prior percutaneous coronary intervention, prior 
coronary artery bypass graft surgery, cocaine use, smoking status); cardiogenic shock on 
arrival; hemoglobin A1C, HDL, LDL, statin therapy, non-statin lipid lowering therapy; name 
of Satellite facility of origin or referring hospital of origin (within a 35 mile radius of Jewish 
Hospital); First medical contact (FMC) time, door time, EKG time, fibrinolytics time, cardiac 
cath lab activation time, cardiac cath lab door time, and device time, and time of day 
categorized into working hours of a business day (Monday-Friday, 0700-1900) and non-
working hours of the day (weekends, holidays, and 1900-0700 7 days a week). 
  Disclosed (shared with anyone other than key personnel listed in the research application): 
Nothing will be disclosed in an individualized form; summarized data only, conclusions and 
descriptive statistics 
 
 b. Please describe why the information you wish to view, collect, and/or disclose is the minimum 
necessary for the research project based on the protocol (reference protocol section(s) or 
page(s)). Do not state “See protocol.” 
In order to thoroughly answer the Research questions related to predictors and factors related 
to the evaluation of the implementation of a STEMI Network protocol, large amounts of data 
need to be viewed and collected. However, data has been minimized. 
3. a. The health information identified in 2, combined with one or more of the identifiers listed 
below becomes PHI.  Please indicate which of the following identifiers, if any, of the subject, 
relative of subject, household member of the subject, or employer of the subject, will be 
viewed, collected, and/or disclosed by you or any other investigator for this research project.  
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Please check () all that apply. 
 
  [] 1. Name (including initials) 
  [] 2. All geographic subdivisions smaller than a State, including street address, city, 
county, precinct, zip code, and their equivalent geocodes, except for the initial 
three digits of a zip code. 
  [] 3. All elements of dates except year, for dates directly related to an individual, e.g., 
date of birth, admission date, discharge date, date of death.  For individuals who 
are 90 years or older, all elements of date, including year, is considered a “direct 
identifier.”  Note: if such ages and elements are aggregated into a single category 
of “age 90 or older” then it is not considered to be a direct identifier. 
  [] 4. Telephone numbers 
  [] 5. Facsimile numbers 
  [] 6. Electronic mail addresses 
  [] 7. Social Security numbers (full or partial, including the final four digits) 
  [] 8. Medical Records numbers, prescription numbers 
  [] 9. Health Plan numbers 
  [] 10
. 
Account Numbers 
  [ ] 11
. 
Certificate/license numbers 
  [ ] 12
. 
Vehicle identification/serial numbers/license plate numbers 
  [ ] 13
. 
Device identifiers/serial numbers 
  [ ] 14
. 
Universal Resource Locators (URLs) for Web sites 
  [ ] 15
. 
Internet Protocol (IP) Address 
  [ ] 16
. 
Biometric Identifiers, e.g. fingerprints, voice prints 
  [ ] 17
. 
Full face or comparable photographic images 
  [ ] 18
. 
Any other unique number, characteristic, or code that could be used to identify the 
individual. (If you abstract any unique identifiers, please specify.) 
 
 b. Additionally, if you are collecting demographic information (e.g. age, gender, ethnicity, 
education, income, etc.), please specify the information that will be viewed, collected and/or 
disclosed for this research study.  
age, gender, race, home zip code  
 c. Please attach a copy of the data collection form when submitting the Complete Waiver.  If the 
data collection form is unavailable, please explain: data collection form is attached. 
 
If the data collection form is unavailable for submission, please note that a data collection 
form determined to be inconsistent with this waiver may impact the ongoing status of 
your study. 
 
4.  Please indicate your sources of the PHI that will be viewed, collected, and/or disclosed for this 
research study.  Please check () all that apply. 
     
  [ ] 1. Physician/clinic records 
  [] 2. Hospital/medical records 
  [ ] 3. Databases collected for informational/reporting purposes 
  [ ] 4. Data previously collected for research purposes 
  [] 5. Diagnostic test results 
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  [ ] 6. Interviews/questionnaires 
  [ ] 7. Other – Please describe: 
 
5.  List the names of all individuals on the research team who will be looking at and/or sharing 
PHI (medical record or other identifiable health information about the subject). 
Julianne Evers, BSN, RN, CCRN; Melanie Hardin-Pierce, DNP, APRN; Celeste Romp, MSN, 
APRN, CCNS, RN-BC 
6.  In order for the Privacy Board to determine that the use and disclosure of PHI involves 
minimal risk to a subject’s privacy, please respond to a, b, and c below.   
 
 a. By law/regulation/policy/study site you may be required to disclose PHI to one or more of the 
following oversight agencies/offices: OHRP, OCR, CMS, FDA, NHORA, ULH RIO, JHSMH 
CAM, UofL IRBs/Privacy Boards, HSPPO, UofL Privacy Office. 
 
Are you planning to disclose PHI from one covered entity to an outside entity or other 
individuals outside the Research Team?  Yes [ ]  No  []  If No, go to 6.b. 
  If so, to whom will you disclose (share) the PHI? 
[ ] 1. Sponsor and/or agents of the sponsor 
[ ] 2. Research oversight offices and collaborators at other institutions 
[ ] 3. Other, please identify: 
 b. Are you planning to retain identifiers in paper and/or electronic format to conduct this study?   
(Note: If you are retaining identifiers such as a list of dates of service, medical record numbers, 
list of names, etc., then you must protect the identifiers you will use to identify potential 
subjects.) 
 
Yes []  No  [] 
 
If no, proceed to the “Attestation of Investigator.” 
 
If yes, please select the longest policy or regulatory retention requirement that is applicable to 
your research project from the list below. If there is a reason to retain identifiers longer than 
any period listed below, please describe in the “Other” section below.  
 
[ ]  University Record Retention Policy (retain research information 5 years post submission 
for publication or publication, whichever is longer) 
 
[ ]  Common Rule (retain research information 3 years following closure of the study) 
 
[ ]  FDA (retain 2 years following FDA submission, approval or FDA notification of 
discontinuation of investigation, whichever is longer) 
 
[ ]  Contractual requirements  
 
[ ]  Other (please explain) 
 
 c. Describe your plan to protect identifiers in paper format from improper use and/or disclosure 
by completing the applicable questions below. 
 c.
1. 
Are you storing PHI in paper form?  Yes [ ]  No  [ ]  If No, please proceed to 
“ATTESTATION OF INVESTIGATOR.” 
  Please describe the permanent location of the paper form.  
Data will be securely stored in a locked file while in paper form prior to being inputted into a 
spreadsheet.  When completed, paper forms will be shredded. As soon as all data have been 
collected and there is no further need to return to a subject’s medical record, the Excel key 
104 
 
linking name and MR # to assigned sequential ID numbers will be destroyed. The data will be 
transferred to an SPSS spreadsheet once received. Data will be secured electronically on the 
PI’s password protected computer in a locked office at Jewish Hospital. 
 
  Please describe the security measures that you will put in place for stored data. 
 
Will the data be kept in a locked file cabinet?        Yes []  No  
[ ] 
Will the cabinet be kept in a locked office or store room?              Yes []  No  [ ] 
Will the area be a locked/limited access area?      Yes []  No  
[ ] 
 
Describe any additional security measures, including the security measures for paper data in 
transit.   
Data will be stored on an encrypted file on password protected computers. Data will not be 
stored on an unauthorized “cloud” type server per HIPPA regulations. If data is transported via 
email or a thumb drive, it will be encrypted for transport. 
 
 
ATTESTATIONS OF INVESTIGATOR 
 
By submitting this document for Privacy Board approval and electronically signing your submission in BRAAN2, 
you attest,  that PHI will not be reused/disclosed to any other person or entity, except: 
 
1) as required by law,  
2) for authorized oversight of the research project, or  
3)for other research for which use/disclosure of PHI would be permitted by the HIPAA privacy regulations.   
 
The researcher, listed below, and his/her entire research team agree: 
 
1) that this Complete Waiver will be used to access only the specific PHI identified in this document. 
2) that only the undersigned will be permitted to use this Complete Waiver to obtain PHI from the entities 
identified in this document.   
3) to share the PHI obtained under this document only with those persons or entities identified by this 
document. 
4) to provide sufficient documentation to any covered entity where PHI is obtained so that an accounting of 
disclosures can be generated. 
5) to maintain, store, and/or transmit any PHI, obtained during this study, on any electronic media 
(server, desktop computer, laptop, PDA/Smart phone, USB drive, DVD/CD or any other electronic 
storage media)  in a manner consistent with the University of Louisville Information Security Policies 
and Standards.   
 
 
PRINCIPAL INVESTIGATOR: 
Julianne Evers, BSN, RN, CCRN  
RESEARCH TEAM: 
Melanie Hardin-Pierce DNP, APRN 
Celeste R. Romp, MSN, APRN, CCNS, RN-BC. 
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Appendix B 
Jewish Hospital Nursing Research Council Approval 
IT
E
M
 
ISSUE/DISCUSSION 
TARGET 
DATE/REPSONSIBLE 
PERSON(S) 
People 
 
Present: Shih-Chia Chung- SMEH 1st Floor Surgery, 
Celeste Romp- KentuckyOne West System Education, 
Debbie Brown- JH PATT, Kim Quinlan- MCE 
Perianesthesia, Stephanie Eitel- MCE Perianesthesia, Brian 
Engelbach- JH 6/7 Towers, and Anette Bickett- MCS- ED. 
 
Guest presenters- Juli Evers, Jewish Hospital STEMI 
Coordinator and staff nurse, Cath Lab 
 
Welcomed our members both in the room and on the 
call/Webinar. 
All  
 
 
 
 
 
 
Celeste Romp/Siga Chung 
Stewardship 
 
Congratulation was given to our poster presenters that 
were selected to present their posters orally during the 
sessions at Research Louisville 2014!  KentuckyOne 
podium presenters from our Legacy JHSMH system 
include: Shih-Chia (Siga) Chung, MSN, RN, CNOR and 
Paula O’Hara, ADN, RN, ONC from 1
st
 floor Surgery at 
SMEH with their poster on “Efficient Instrument Use: 
Enhancing Surgical Care Quality Improvement Project” 
and Kathleen Hall, BSN, RN, PCCN from 3 East at Jewish 
Hospital with her poster on “Bedside Shift Report: A Pilot 
Evidence Based Practice Project”. Congratulations!  There 
were only 6 posters selected to be presented at the event 
from all of the local facilities, and we had 2 of them! 
Celeste/All 
 
 
 
 
 
Quality Celeste presented a continuing education program to the 
council titled “Developing and Presenting your 
Professional Poster”.  It covered not only the key parts 
and special considerations of professional posters, but 
also how to use Microsoft Powerpoint to develop and edit 
one, with or without a template.  It also covered 
important behaviors and “How to’s” for presenting a 
poster during a conference. Although a review for some, 
Celeste/All 
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members found the information very helpful and were 
glad to have it in handout format for future reference. 
Siga and Celeste updated the council on the results of the 
Change of Shift study and reviewed the rough draft of the 
poster with the group.  Although there were actually 233 
nurses that accessed the survey, only 194 completed it. 
16% only answered the first or second screen with the 
demographics and did not click “next” to go to the page of 
the survey with the actual survey/study questions. In 
hindsight, the team decided nursing surveys should not 
have separate “pages” for different sections.  Results of 
the survey were included in the handout and were 
reviewed and discussed.  Then the poster draft was 
reviewed.  Feedback and input on wording was received.  
A graph will be added. 
Celeste updated the council on the results of the Alarm 
Fatigue quality improvement project and reviewed the 
rough draft of the poster with the group. Due to the need 
to begin collecting the alarm data quickly, the education 
and implementation stages had been quite short, but the 
data was able to be collected in time for this year’s 
Research Louisville.  With additional time and education, 
there may have been more nurse customization of 
alarms. Regardless, though, the team was able to 
decrease the total number of alarms by 39%!  Results of 
both the alarm data and poster draft were reviewed and 
discussed with the members.  A graph will also be added 
to this poster with the alarm data before and after 
results.  
 
 
 
 
Siga Chung/Celeste/All 
 
 
 
 
 
 
 
 
 
Celeste/All 
 
Growth 
 
Juli Evers, STEMI coordinator and staff nurse in the Jewish 
Hospital Cath lab, as well as a DNP student at UK, 
presented her new study, An Evaluation of the 
Implementation and Efficacy of a STEMI Network in the 
Southeastern United States, to the group for review and 
approval.  The study is a descriptive, retrospective chart 
review designed to evaluate the impact of the 
implementation of a STEMI Network at Jewish to see if it 
decreased the door-to-balloon time in which STEMI 
patients were treated with Coronary Intervention. The 
members were interested in the study and are looking 
forward to seeing the results.  Members voted and 
unanimously approved the study. 
The virtual library dissemination was discussed with the 
Celeste/ All 
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group.  Official dissemination information had recently 
been sent out by HR that included a general informational 
flyer.  Members felt the flyer could be posted in the units, 
but additional information could be provided to nurses to 
let them know how it could benefit them, specifically if 
they are in school and need literature searches done or 
articles retrieved.  The members felt dissemination should 
include multiple methods including e-mail, newsletter, 
and other meetings (like Shared Governance) too reach as 
many people as possible.  Siga and Celeste will work to 
draft an e-mail and newsletter dot points for 
dissemination, and will included the “officially made” flyer 
for posting. 
The council also discussed the upcoming Research 
Louisville symposium, Sept 19
th
, 2014.  Members were 
encouraged to save the date and be available to assist 
with registration, decorating, and poster set up. 
 
 
Siga and Celeste 
All 
 
Innovation 
 
The next meeting will be October 22
nd
, 2014, 1-3PM on 
the 15
th
 Floor Frazier Boardroom.  September’s meeting 
will be Research Louisville Sept 19
th
, 2014. 
Webinar information for the council meeting: 
Siga/ All 
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Appendix E 
Kentucky One Hospital, Jewish Hospital Final Facility Approval 
Re: STEMI Network Study IRB Documents 
Shelburne, Dorie 
Sent: Thursday, October 09, 2014 12:11 PM 
To: Evers, Julianne 
Cc: Cravens, Lorie 
     
Great job! Approved. 
Dorie Shelburne RN, BSN, MSBC 
Director of Nursing for Intensive Care, Emergency Department, and Logistics Center 
Kentucky One Health 
Jewish Hospital 
 
On Oct 7, 2014, at 1:32 PM, "Evers, Julianne" <JulianneEvers@KentuckyOneHealth.org> 
wrote: 
Hi Dorie, 
 This again is Julianne Evers (I emailed you earlier-so I am sorry for the multiple emails). 
However, I am emailing you with the U of L IRB application and Data Collection Tool in 
addition to the latest version of the STEMI-Written Protocol for the STEMI Network study I am 
hoping to do for my DNP at UK. I don't know if you remember, but I spoke with you a year or 
two ago in regard to my collecting data for this project. 
I am working with Celeste Romp on this project. I look forward to any thoughts, questions, 
and/or approval you may have. 
 I am cc-ing this to Lorie Cravens as well. 
Thank you so much for your time and I look forward to hearing back. 
Juli Evers 
<IRB Submission- STEMI Network- J. Evers- 14.0687.pdf> 
<STEMI- Written Protocol.pdf> 
<STEMI- Data Collection Tool.pdf> 
<STEMI- Waiver of Authorization.pdf> 
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Appendix F 
 
An Evaluation of the Implementation and Efficacy of a STEMI Network  
in the Southeastern United States Protocol 
Data Collection Form 
 
1. Demographics 
 
a. Age   c. Gender 0. Male 1. Female 
b. Race   d. Height (cm)   
  1. Caucasian  e. Weight (kg)   
  2. African American  f. Zip Code   
  3. Hispanic      
  4. Other _______________       
 
 
2. Diagnosis/Comorbidities/Treatments (Circle all that apply) 
      
a. Prior PCI f. Diabetes non-insulin requiring k. Cocaine use 
b. Prior MI g. Diabetes – no treatment l. Cardiogenic shock on 
arrival 
c. Prior CABG h. Hypertension m. Statin therapy 
d. Diabetes-diet controlled i. Dyslipidemia n. Non-statin lipid 
lowering therapy 
e. Diabetes-insulin requiring j. Smoking   
 
3. Principal diagnosis   
 
 
4. Labs: a. HgA1C   c. LDL  
  b. HDL   d. Total cholesterol  
 
5. Presentation:  Circle one 1. Walk-in 3. Transfer 
2. EMS   
 
 
6. Day of presentation:  Circle 1. Non-weekend 3. Holiday  
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one 2. Weekend   
 
7. Satellite Medical Center: 1. St. Mary’s Elizabeth 5. JH Northeast 
  2. JH East 6. JH Shelbyville 
  3. JH South 7. Flaget 
  4. JH Southwest 8. Other _____________ 
 
8. Enter all as MILITARY TIME:  
    
 a. First medical contact time:  
 b. Jewish Hospital door time:  
 c. EKG time:  
 d. Fibrinolytic time:  
 e. Cardiac Cath activation time:  
 f. Cardiac Cath lab door time:  
 g. Device time:  
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